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ABSTRACT
Lewis, Todd Warren Ph.D., Biomedical Sciences Ph.D. program, Wright State
University, 2017. A novel system for detection of DNA double strand breaks and repair
in human cells
Imperative to genomic stability is the ability of the cell to repair damaged DNA
which can occur from numerous endogenous byproducts of metabolism or exogenous
components from the environment. The Fanconi anemia pathway is a DNA repair
mechanism used by human cells to resolve multiple forms of DNA damage including
interstrand crosslinks (ICL). Fanconi anemia (FA) is an autosomal recessive inherited
disorder characterized by genome instability, developmental abnormalities, cancer
predisposition and bone marrow failure. FA is attributed to a mutations in at least 18
genes (FANCA-FANCT) that play a concerted role in DNA repair. FANCT is the latest
discovery in the FA pathway and is a UBE2T ubiquitin conjugase. An FA patient with
biallelic germline mutations in FANCT presented with the classical symptoms of FA with
the exception of hematopoietic indications. Both mutations, a maternal duplication and a
paternal deletion of exons 2-6, were AluY mediated. Upon further evaluation it was
determined that the FA patient had a reversion of the maternal duplication back to a WT
allele which restored FANCT function in the hematopoietic lineage. The genomic
reversion was also attributed to an Alu mediated recombination (AMR) event. The
factors that led to the AMR event were unknown and provided reason to investigate
further. The promise of harnessing the mechanism to utilize a genomic duplication
reversion could be of importance for therapeutic interventions.
No current human cell line models were sufficient to address what factors are
involved in the FANCT reversion, so a novel Dual Fluorescence (DF) model system was
created in a HeLa cell line to test the hypothesis that Alu mediated homology directed
iv

repair is sufficient to explain genetic reversion of a partially duplicated FANCT locus.
The DF model system emulates elements of the FANCT locus using partial intronic
sequences and Alu elements found in the patient’s duplicated FANCT locus. Key to the
model system design is the incorporation of TOM and eGFP fluorescent marker genes
and an I-Sce1 recognition site into the ectopic locus. I-Sce1 is a rare endonuclease found
in yeast, with no known recognition site found in humans and when expressed in the DF
cells will cause a targeted DNA double strand break. The fluorescent marker genes are
separated and flanked by Alu elements. After an I-Sce1 induced DSB, it is possible that
AMR will occur and eliminate one of the fluorescent marker genes, thereby shifting
fluorescence of the cell. This shift in fluorescence can be detected by microscopy or flow
cytometry. To test whether Alu mediated homology directed repair is sufficient to explain
genetic reversion of a partially duplicated FANCT locus, multiple DF cell lines were
created that vary in; location of the I-Sce1 recognition site, number of Alu elements and
the presence of repetitive DNA sequences.
Flow cytometry of the DF cells after an I-Sce1 mediated DSB, reveals that
recombination of the proximal Alu elements is the most likely repair outcome. Further
evaluation of DF cell line recombinants by Flow Assisted Cell Sorting (FACS) and DNA
sequencing disclose that the model system can differentiate between homology and nonhomology directed repair. To test if Alu mediated homology directed repair can facilitate
a genetic reversion, canonical DNA repair proteins in homology directed repair (HDR)
and non-HDR pathways were impaired. The results of this experiment provide evidence
that only HDR pathways support the genetic reversion. Upon evaluation of a FANCT
null cell line in the DF model and the well-established U2-OS GFP model, both models
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indicate FANCT is involved in homology directed repair. The unique DF model system
was able to determine that FANCT is also involved in non-HDR. These experiments
provides evidence for the novel finding of FANT’s role in HDR and non-HDR outside of
ICL resolution via the FA pathway. Another aspect to examine when assessing AMR
causality is what factors may lead to the initial DNA break occurrence. There is evidence
in multiple diseases that an AMR event was caused by a DNA break at a microsatellite
sequence. To address the question of how repetitive DNA sequences influence Alu
mediated homology directed repair, the DF cell lines were modified to include multiple
microsatellite motifs. The results of an I-Sce1 induced break juxtaposed to a
microsatellite sequence reveal that both homology and non-homology directed
recombination events are significantly impaired, presumably by the formation of DNA
secondary structure. The results of this project suggest that Alu mediated homology
directed repair is sufficient to explain genetic reversion of a partially duplicated FANCT
locus. Additionally, the development of the DF cell lines provide a novel model system
for detection of DNA double strand breaks and repair in human cells.
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INTRODUCTION
Imperative to genomic stability is the ability of the cell to repair damaged DNA,
which can occur from numerous endogenous byproducts of metabolism or exogenous
components from the environment (Abbotts et al., 2014; Guirouilh-Barbat et al., 2014).
DNA damage can directly cause single strand breaks (SSB) and double strand breaks
(DSB) or breaks could arise from DNA repair processing of adducts, lesions or
replication collapse (Gent et al., 2001; Johnson & Jasin, 2001; Rothstein et al., 2000).
DSB’s are particularly detrimental because they can lead to genomic rearrangement,
tumorigenesis and cell death if not repaired correctly and efficiently.

Fanconi anemia promotes genome instability
Fanconi anemia (FA) is an autosomal recessive inherited disorder characterized
by genome instability, developmental abnormalities, cancer predisposition and bone
marrow failure (Kalb et al., 2006). FA is attributed to mutations in any of at least 18
genes (FANCA-FANCT) that play a concerted role in DNA repair (Wang &
Smogorzewska, 2015). FA patients are particularly sensitive to DNA interstrand
crosslinks (ICLs), which covalently link DNA strands and block replication and
transcription (Auerbach, 2009). For clinical diagnosis, patient cells will have increased
chromosome breakage if subjected to an ICL agent such as mitomycin C (MMC) or
diepoxybutane (DEB) when compared to healthy individuals, due to the inability to
effectively repair the damage (Shimamura et al., 2002). Chromosome abnormalities
1

include mitotic chromosome breaks, chromatid breaks, acentric fragments and chromatid
exchanges and contribute to the clinical presentation of the disease (Figure 1) (Cirkovic
et al., 2011). FANCT, an E2 ubiquitin conjugase (UBE2T), was recently classified as the
18th FA protein member when it was found deficient in an FA patient (Hira et al., 2015).
It is known that after the FA core complex recognizes an ICL, it initiates an E1-E3
ubiquitination chain that includes FANCT and FANCL (E3 ubiquitin ligase) (Figure 2).
FANCL will ubiquitinate FANCD2 as part of the ID complex (FANCI and FANCD2),
thereby activating the ID complex to interact with other HDR repair proteins and resolve
the ICL (Kee & D’Andrea, 2010; Takata et al., 2006). Interestingly, some Fanconi
anemia proteins are not used exclusively for just ICL repair, but are also involved in other
types of repair such as homology directed repair (HDR) (Patel, 2007). It is currently
unknown what the function of FANCT is outside of the FA pathway, but it could
additionally play a role in HDR or non-HDR pathways.
Fanconi anemia typically presents with growth abnormalities and anemia, but a
unique FA phenotype was revealed when fibroblasts from a 16 year old FA patient
100166/1 were analyzed (Rickman et al., 2015; Virts et al., 2015). Curiously, patient
100166/1 displayed most of the typical clinical presentations of FA, that include
developmental and growth abnormalities, but the patient unexpectedly did not display
bone marrow failure and anemia in the hematopoietic cell lineage. Examination of the
genotype in the patient’s non-hematopoietic cells revealed that one allele is partially
duplicated (maternal) and the other allele contains a partial deletion (paternal). FA is an
autosomal recessive disease so the fact the patient can no longer produce a functional
FANCT protein in these tissues leads to the phenotype. When observing the genotype in
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Figure 1: Genome instability in Fanconi anemia patient. A variety of chromosome
abnormalities appear when Fanconi anemia patient cells are challenged with DEB an
ICL agent. (A) Chromosome break, (B) Chromatid break, (C) Acentric fragment, (D)
Chromatid exchanges (Cirkovic et al., 2011)
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Figure 2: FA proteins and repair activation. Within the FA pathway the FA core
complex will recognize DNA damage and initiate the ubiquitination cascade of E1,
FANCT, and FANCL. This will elicit a monoubiquitination of the ID complex:
FANCD2 and FANCI. Once the ID complex is ubiquitinated it recruits HR proteins to
complete the DSB intermediate step.
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the hematopoietic lineage it was determined that the partial duplication had reverted back
to wild type (WT) and produced a functional FANCT protein that enables amelioration of
the anemia phenotype. Detailed examination of the parental and patient genotypes
suggested that the maternal duplication/reversion and paternal deletion of the FANCT
locus were due to Alu mediated recombination (AMR) events involving AluY elements
(Figure 3).

Alu elements possess mutagenic potential
An Alu element is from the family of repetitive elements that are considered
transposable elements under the classification Short Interspersed Nuclear Element
(SINE) and consist of ~300 bp. A transposable element is known as a mobile genetic
element due to its ability to transfer genetic information to other parts of the genome. An
Alu element is a Class I retrotransposon that is initially transcribed from DNA to RNA by
RNA Pol III, and then transcribed back to DNA by reverse transcriptase. SINEs do not
encode for reverse transcriptase, instead using reverse transcriptase produced from a
trans-acting Long Interspersed Nuclear Element (LINE), and therefore are nonautonomous (Dewannieux et al., 2003).
Alu elements are primate specific, occurring prevalently throughout the human
genome with copy numbers exceeding 1 million (Batzer & Deininger, 2002; Häsler &
Strub, 2006; Lander et al., 2001). There are variations in Alu sequences that have been
classified into ~30 subfamilies, with the AluY subfamily being the most active for
retrotransposition in the hominoid lineage (Hormozdiari et al., 2011). Conserved
throughout eukaryotes, Alu elements can induce genomic instability either by
interrupting a gene directly during transposon insertion, or by facilitating aberrant

5

Figure 3: Model for patient reversion of partially duplicated FANCT allele. The
numbered gray boxes represent exons. The yellow boxes indicate AluY elements. (A)
The mother has one partially duplicated allele and the father one partially deleted allele.
Both parents have a functional WT allele and do not display the phenotype of FA, an
autosomal recessive disease. (B) The progeny (FANCT patient) displays the FA
phenotype in all tissues except hematopoietic cells due to a maternal duplication and
paternal deletion. (C) In the patient’s hematopoietic cell lineage the maternal
duplication was reverted back to a functional WT allele due to Alu mediated
recombination.
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recombination following a DNA double strand break (DSB) due to sequence homology
of nearby Alu elements. Alu mediated recombination (AMR) can occur when there is a
DNA break between two Alu elements, followed by a recombination between the
upstream Alu and downstream Alu, thereby facilitating a genomic deletion of the
intervening DNA sequence. Inappropriate Alu element recombination serves as a
facilitator of at least 33 diseases and 16 cases of cancer that are attributed to unequal
homology directed repair following a DSB with flanking Alu elements (Deininger &
Batzer, 1999).
This project will focus on direct Alu repeat elements, considering that inverted
Alu repeat elements have been selected against over time due to extreme genomic
instability (Lobachev et al., 2000). With insight gained from examination of tumor
suppressor gene mutations, it has become apparent that Alu mediated recombination
(AMR) has a major impact pertaining to loss of function in many DNA repair proteins
(Table 1). The results of this study support that AMR events are not isolated incidents,
and may be involved in the impairment of other DNA repair genes. It should be noted
that the density of Alu elements within a locus directly correlates to the incidence of
AMR as represented by the increased number of mutations in the Alu dense MSH2,
BRCA1, and VHL genes, in comparison to the relatively less dense MLH1 gene
(Belancio et al., 2010; Mazoyer, 2005; van der Klift et al., 2005).
Concurring with the Alu density finding, another study analyzed the human
genome for AMR deletion events and deduced that 75% of deletion events occurred
when the Alu elements were less than 1kb apart. The likelihood of Alu mediated
recombination also decreases as the distance between Alu regions increases. In addition,
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Gene

Disease

Origin

10x MLH

HNPCC

Germ line

32x MSH2

HNPCC

Germ line

30x VHL

VHL

Germ line

15x hCAD

Hepatoma

Somatic

5x MYB

T-ALL

Somatic

7x MLL1

AML

Somatic

23x BRCA1

Breast cancer

Germ line

Table 1: Alu mediated recombination derived mutations in tumor suppressor
genes. Number of unique patient mutations attributed to recombination of Alu
elements in select tumor suppressor genes (column 1). The disease a mutation is
implicated in (column 2). Type of tissue the mutation is observed in (column 3).
(Adapted from Belancio et al, 2010)
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it was found that 490 of the 492 AMR deletions studied were due to Alu elements in
direct orientation (Sen et al., 2006). These data suggest that AMR is not an isolated
occurrence, especially when the Alu elements are in parallel orientation. Therefore, it
would be valuable to create a model system within human cells that has the potential to
identify factors involved in AMR.
While AMR primarily presents as deletions there is also the possibility of
translocation or expansion events. A partial tandem duplication attributed to AMR is
found in a subset of acute myeloid leukemia (AML), trisomy 11 and Fanconi anemia
patients (Strout et al., 1998; Virts et al., 2015). FANCA is a subclass of FA in which
both alleles are mutated with either a point mutation, frameshift, deletion or expansion
that leads to a non-functional protein. Interestingly several cases have been identified in
which one allele has reverted back to a wild type allele in the lymphohematopoietic cell
line by AMR and corrected the FA phenotype (De Rocco et al., 2014; Morgan et al.,
1999). This functional correction is quite significant because the reversion could provide
a proliferative advantage to the reverted cells and thus repopulate the bone marrow
(Waisfisz et al., 1999). While it is hypothesized that a genetic reversion in some diseases
are due to Alu mediated homology directed repair, it is not always clear why the initial
break occurred.

Microsatellite sequences are hotspots for recombination
Another aspect to examine when assessing AMR causality, is what factors may
lead to the initial DNA break occurrence. Once a DSB is made and repaired via AMR,
the resulting recombination product will not provide details of break origin because it
will recombine on the Alu elements and lose the intervening sequence resulting in a
10

deletion and discarding where the initial break occurred. While there are a number of
possibilities that could lead to a DSB there are also some predictable sequence dependent
regions where a DSB is more likely to occur. Common fragile sites are frequently areas
of genomic rearrangement, and are often identified when observing a metaphase spread
the fragile sites will appear as constrictions or gaps when cells are exposed to aphidicolin
(Schwartz et al., 2005). While common fragile sites are thought to occur in all
individuals, rare fragile sites are not as common (Glover et al., 1984; Zlotorynski et al.,
2003). Some fragile site loci can be attributed to an expanded microsatellite DNA
sequence such as trinucleotide repeat sequences (TNR’s), G-rich DNA or triplex forming
sequences (TFS) capable of forming secondary structures (DNA hairpins, triplexes or
quadraplexes) that can induce replication fork stalling and fork collapse if not properly
repaired (Ma et al., 2012; Sutherland, 2003).
While TNR’s are one type of microsatellite sequence that contains a repeating
sequence of three nucleotides, other microsatellite sequences can consist of a repeating
sequence of ~1-10 nucleotide sets. TFS’s can be an uninterrupted microsatellite repeat
sequence or have a few interruptions within the repeat tract. For simplicity sake, TFS will
be referred to as a microsatellite sequence throughout this document. TFS’s form
secondary structures where a ssDNA stretch of homopyrimidines “fall back” on a
duplexed section of the motif and through Hoogsten bonding form a secondary structure
known as a triplex (Figure 4). During replication, a single strand break in the template
strand can develop into a double strand break once the replication fork reaches the break.
The nascent strand would stop at this point and result in a DSB (Branzei & Foiani, 2010;
Dalgaard, 2011; Mirkin & Mirkin, 2007). To experimentally induce replication
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Figure 4: Microsatellite sequences capable of DNA secondary structure
formations. (A) CAG trinucleotide repeats that have conformed to a hairpin structure.
(B) Single stranded homopyrimidine strand can Hoogsteen base pair to the duplexed
DNA and form a triplex structure. (C) GCC trinucleotide repeats can form a Gquadruplex structure.
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dependent DNA breaks, replication inhibitors such as aphidicolin or hydroxyurea are
used to slow down the replicative polymerases. By specifically inhibiting the
polymerases it can initiate uncoupling of the replisome from the replicative CMG
(CDC45, GINS, MCM 2-7) helicase, considering that the helicase is not kinetically
affected by these replication inhibitors. This, in turn, will produce long stretches of
ssDNA that have an increased potential for damage and breaks (Chan et al., 2012). Once
the nascent strand encounters the single strand break, it is effectively converted into a
double stranded break (Caldecott, 2008; Petermann & Helleday, 2010). Combining a
hypersensitive TNR or TFS locus with the use of low dose replication inhibitors will
increase the abundance of ssDNA, thereby exacerbating the secondary structure forming
ability of the DNA sequence. The in vivo formation of DNA secondary structures can
increase the likelihood of genomic instability (Yang et al., 2003).
There is evidence in multiple diseases that an AMR event was caused by a DSB
initiated at a microsatellite sequence. Amongst subgroups of FANCA, Birt-Hogg-Dube
Syndrome (BHDS) and Glanzmann Thrombasthenia (GT) patients; microdeletions and
microinsertions were found within 5 nt. of tetranucleotide CCTG/CAGG flanking motifs
indicating hotspots within the gene, in addition to a GAA/TTC repeat tract in another
subset of FANCA patients (Benhammou et al., 2011; Gregory et al., 2001; Levran et al.,
1997; Li & Bray, 1993). These breaks were repaired by an alternate mechanism that did
not result in AMR but rather a frameshift that allows the breakpoint origin to be tracked.
If AMR had proceeded, the intervening sequence would be lost and the breakpoint
undetectable, as presented in other patients of FANCA, BHDS, and GT originating from
AMR. This displays the potential for specific motifs CCTG/CAGG, GAA/TTC (also
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implicated in microsatellite instability attributed to hairpin and triplex formations
respectively) to induce genomic instability by inducing AMR in three independent
diseases: FANCA, BHDS and GT. Once a DNA double strand break occurs in the
intervening sequence between Alu elements, there are several possible homology directed
repair mechanisms that could account for the AMR.

DNA double strand break repair mechanisms
The two primary forms of DSB repair are non-homologous end joining (NHEJ)
and homologous recombination (HR) (Pierce et al., 2001). Homologous recombination is
primarily a fidelitous process that predominates during S/G2 phases when the sister
chromatid is available to use as a template, and requires broken chromatid strand invasion
into the sister chromatid based upon sequence homology (Saleh-Gohari & Helleday,
2004). For strand invasion to occur, the DSB ends must undergo resection of DNA 5’
ends which occurs primarily in S/G2 phases of the cell cycle. The resection of the DNA
5’ ends of the DSB will expose DNA 3’ tails, that are subsequently used for strand
invasion of the sister chromatid (X. Li & Heyer, 2008; Symington & Gautier, 2011). In
contrast, NHEJ religates the broken DNA ends and does not require significant DNA end
processing but usually results in the loss or addition of a few nucleotides, which makes it
a potentially mutagenic process (Davis & Chen, 2013).
After a DNA double strand break, the protein kinase ATM will act as a transducer
to activate effectors of DNA damage repair in both the HR and NHEJ pathways
(Marechal & Zou, 2013; Wang et al., 2013). Competition between HR and NHEJ that
can influence DSB outcomes, and a number of DNA repair proteins have been implicated
to influence the pathway choice, ultimately with resection being the decisive point
14

between HR and NHEJ pathways (Chapman et al, 2012; Jain et al., 2009). For the HR
pathway, there is growing evidence that C-Terminal Binding Protein 1-Interacting
Protein (CtIP) initiates the first step in the DNA resection process required for homology
directed repair (Sartori et al., 2007; You et al., 2009). Intermediate to the homologous
repair process, RAD51 recombinase is required for the free 3’ DNA tail to search for a
homologous DNA sequence and invade the sister chromatid to use as a repair template
(Baumann & West, 1998). In contrast, non-homologous repair does not require resection
of DNA ends. Ku proteins first recognize and bind to non-resected DNA ends and
facilitate the binding of DNA-dependent protein kinase (DNA–PK). Once bound to the
DNA, DNA-PK will recruit additional DNA processing and repair proteins required for
the NHEJ process (Pawelczak et al., 2011).
Classical HR and NHEJ are the predominating forms of DNA repair in the
genome, but when a DSB occurs near repeated sequence homologies alternate repair
pathways may be utilized (Huertas, 2010; Liang et al., 1998). When repeated sequences,
such as an Alu element in direct repeat orientation, are in close proximity flanking a DSB
the invading strand could invade the second repeat of the sister chromatid and lose the
intervening sequence between repeats (Kataoka et al., 2013; Witherspoon et al., 2009).
This is a mutagenic process termed unequal homologous recombination (uHR), and is
defined as intrachromosomal if it is within the same allele, and intermolecular if it uses
the sister chromatid for repair (Figure 5).
Another possible mutagenic outcome is an intrachromosomal event termed single
strand annealing (SSA), which is intramolecular and does not use the sister chromatid.
For SSA, once resection has exposed the region of homology on the opposite DNA
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Figure 5: Select DNA DSB homology directed repair mechanisms. Rectangles
represent Alu elements on DNA strands. All HDR pathways presented are DNA 5’ end
resection dependent. (A) Precise homologous repair invades the sister chromatid and
provides faithful repair. (B) Unequal homologous repair results in loss of intervening
sequence. (C) Single strand annealing is an intrachromosal recombination and results
in loss of intervening sequence.
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strand, it aligns and reanneals, possibly forming 3’ flaps that are subsequently excised
from the recombinant product (Fishman-Lobell et al, 1992; Jain et al., 2009). The
resulting recombination products of SSA and uHR can appear the same since the
intervening sequence between the Alu’s will be deleted and the sister chromatid is an
exact copy of the other strand before damage (Kim et al, 2001; Vidal et al, 2002). To
help understand the underlying DNA break and repair factors involved in Alu mediated
homology directed repair, it would be extremely valuable to have a model system that
can emulate an Alu mediated genetic reversion in human cells.

Development of a novel DNA repair reporter system
A widely accepted reporter assay for determination of homology directed repair
uses a genetically engineered cell line containing the DR-GFP construct (Moynahan et
al., 2001; Nakanishi et al., 2011). In this model a full length of the GFP gene is located
approximately 3.7 kb upstream of a truncated GFP gene. The upstream GFP gene has an
I-Sce1 recognition sequence placed into the GFP reading frame and introduces a stop
codon, whereas the downstream GFP fragment is 5’ and 3’ truncated, therefore no GFP
protein is produced. I-Sce1 is rare yeast endonuclease that has no known recognition site
in the human genome and will induce a DNA double strand break at a specific 18 bp
DNA sequence. After I-Sce1 expression in the DR-GFP system, an I-Sce1 induced DSB
in the upstream GFP fragment can use the downstream GFP fragment as donor template
to repair the break by HDR after 5’ resection has occurred (Figure 6). Since the
downstream GFP fragment (template for repair) does not possess an I-Sce1 recognition
site (with a stop codon) the functional WT GFP will be restored and GFP positive cells
can be detected by flow cytometry. There are several drawbacks to using the DR-GFP
17
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GFP
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Figure 6: Schematic of recombination in U2-OS DR-GFP cell lines. DR-GFP
construct contains an upstream full length GFP coding fragment interrupted with an
I-Sce1 recognition site that contains a stop codon. In addition, there is an iGFP fragment
3.7 kb downstream which contains an internal GFP sequence that is missing the 5’ and
3’ ends of the coding sequence. After a DSB the broken 3’ DNA end in the upstream
element can use the coding sequence in the iGFP fragment as a donor template and
restore the GFP to a functional state.
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Figure 30: FANCT is involved in HDR

system as a model for the genetic reversion observed in the patient. First, the designed
regions of homology are based on an extraneous GFP DNA sequence and not Alu
elements. Second, the system can only detect HDR events; to ascertain insight into other
forms of DNA repair, additional assays would have to be performed. Thirdly, the DRGFP model only contains 2 segments of homology (GFP), whereas the duplicated patient
locus contains 3 segments of homology (Alu).
To specifically address factors involved in the hypothesized Alu mediated
FANCT genetic reversion, a novel Dual Fluorescence (DF) model system was created by
our lab to emulate elements of the FANCT endogenous locus (Figure 7). The DF cell line
model differs from the DR-GFP system by expressing TOM and eGFP as the default state
that will lose one or both fluorescent markers if mutagenic recombination occurs. The
primary expected outcome is an HDR event, with recombination facilitated by the Alu
elements proximal to the DSB and thereby shifting fluorescence. In contrast, the DRGFP model begins with no fluorescence as default and then will shift to green if an HDR
event occurs. The key advantage of the DF model system is that, like the endogenous
FANCT locus, it contains Alu elements as segments of DNA homology. Additionally,
the new DF model system has the ability to detect differing recombination outcomes with
only one highly sensitive assay.
This project utilized the novel DF model system to support the hypothesis that
Alu mediated homology directed repair is sufficient to explain genetic reversion of a
partially duplicated FANCT locus. Specifically, I wanted to determine the following
aims: i) What are the patterns of Alu mediated homology directed after an inducible DNA
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Figure 7: Representation of how the model system reversion emulates patient
reversion. (A) Partial duplication of the maternal FANCT allele (B) The ectopic site
in the DF2 cells emulate the partial duplication in the patient’s maternal allele. (C)
Possible recombination product in the DF2 cell line after an I-Sce1 directed DSB. (D)
Reversion of partial duplication to wild type FANCT allele.
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double strand break, ii) Which DNA repair pathways are involved in DSB resolution, and
iii) How do repetitive DNA sequences influence Alu mediated homology directed repair.
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MATERIALS AND METHODS
Stable integration of DF constructs
The Flp recombinase system is used as a method of delivery to stably integrate a
donor DNA construct into an acceptor locus at a specific location in the genome. Our lab
has previously constructed the HeLa/406 acceptor line that contains a single integrated
ectopic FLP Recombinase Target (FRT) site (Figure 8). The FRT site is specifically
targeted by FLP recombinase to cleave the FRT sites of the chromosome and a donor
plasmid simultaneously, and integrate the donor plasmid into that exact location
(chromosome 18p11.22). To aid in selection of successful recombinants, the FRT is
flanked by hygromycin phosphotranferase (upstream) and thymidine kinase
(downstream) markers. Before insertion of donor DNA within the FRT site, the cells are
hygromycin resistant and ganciclovir sensitive. Once there is successful insertion of
donor DNA into the FRT site, it will disrupt the TK reading frame and cells are no longer
sensitive to ganciclovir. The acceptor cell line was tested by Southern blot for
verification of single insertion of the FRT site (Malott & Leffak, 1999). The acceptor cell
line is co-transfected with pOG44 vector (Invitrogen) that expresses the FLP recombinase
and one of the experimental donor DF constructs at a 10:1 pOG44 / DF construct molar
ratio. Within the DF donor construct is a promoterless neomycin resistance gene that
forms a Hyg-Neo fusion gene after successful insertion into the acceptor cell line.
Twenty-four hours after transfection the cells are placed on selection of 400 ug/ml
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Figure 8: Creation of stable ectopic cell lines. Acceptor cell line is co-transfected
with the ectopic (DF) construct and pOG44. The pOG44 plasmid expresses the FLP
recombinase enzyme and then facilitates the recombination that will incorporate the
ectopic construct into the acceptor cell line. The integrated construct shown here is a
reference DF construct, more detail is presented in following sections.
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geneticin (Gibco) for 10 days. For the following 8 days, cells are placed in 20 uM
ganciclovir (Sigma) for 48 hours and then switched to geneticin for 48 hours, and
continued for 2 cycles. All DF cell lines have been created and cloned out for a stable
integrant. Additionally, PCR was conducted with primers in the acceptor only and donor
only sites so that the PCR product will cross the insertion junction to verify correct
integration as determined by the presence of PCR product and PCR product size. A total
of 12 stable cell lines was generated for experimental use in this project.

Expression of I-Sce1 endonuclease in human cells
DF cells in a 6-well tissue culture plate (Falcon) containing ~6 x 105 cells/well
were trypsinized and transfected with Lipofectamine 2000 (Invitrogen) and 8 ug I-Sce1
plasmid as per manufacturer’s protocol. Dulbecco’s Modified Eagle’s Medium (DMEM)
supplemented with 20% Fetal Bovine Serum (FBS) was replaced after 24 hours after
transfection to remove any lingering transfection complexes. The I-Sce1 plasmid
produces an HA tagged form of the I-Sce1 endonuclease that is recognized by anti-HA
antibody for protein detection. A time course optimization for expression was performed
by immunoblotting, and it determined peak expression of I-Sce1 endonuclease was at 24
hours post transfection and undetectable by 72 hours post transfection (Figure 9). Cells
were grown for 8 days after HA-Sce1 transfection and passaged accordingly until
harvested for flow cytometry.

siRNA treatment
DF cell lines in a 6-well tissue culture plate (Falcon) containing ~4 x 105
cells/well were trypsinized and transfected with Lipofectamine 2000 (Invitrogen) and
100 nM (final concentration) of small interfering RNA (siRNA) pool (an equal molar
24

Figure 9: Peak I-Sce1 protein expression is at 24 hours post transfection. The
western blot indicates that I-Sce1 expression is greatest between 24-48 hours.
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mixture of 4 different siRNAs targeting the same transcript) (Hs_RBBP8 SI1027416)
targeting CtIP, as per manufacturer recommendations. Control experiments were
performed in parallel using a non-targeting All-Stars siRNA (Qiagen SI03650318). At
24 hours post siRNA transfection, cells were trypsinized and transfected with
Lipofectamine 2000 (Invitrogen) and 8 ug I-Sce1 plasmid as per manufacturer
recommendations.

Small molecule inhibitor treatments
Small molecule inhibitors were used to inhibit the functions of some canonical
repair proteins. Rad51 inhibitor (Rad51, B02 Sigma SML03664 10 uM), DNA-PK
inhibitor (Nu7026, Selleckchem S2893 10 uM), ATM/Kinase inhibitor (caffeine, Sigma
C0750 2 mM), ATM inhibitor (Ku60019, Sigma SML1416 1 uM). The small molecule
inhibitors were added at the same time of I-Sce1 transfection. A total of 6 x 105
cells/well of a 6 well plate were trypsinized and transfected with Lipofectamine 2000
(Invitrogen), 8 ug I-Sce1 plasmid, inhibitor as per manufacturer recommendations. The
inhibitors were used for 3 days after transfection to inhibit the targeted proteins
throughout I-Sce1 expression.

Single cell sorting and PCR
DF2 cell lines were subjected to I-Sce1 transfection and allowed 8 days of post
transfection recovery for full fluorescence separation. A total population of (~5 million
cells) was then prepared for cell sorting by centrifugation at 300 x g for 3 min @ 4 °C.
The pellet was then re-suspended in 1 ml FACS buffer (Hank’s Balanced Salt Solution,
25 mM HEPES, 1 mM EDTA, 1% BSA and 2% FBS) and filtered through a 35 μm cell
strainer tube (Falcon 352235). Cell sorting was performed at Cincinnati Children’s
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Medical Hospital (CCMH) Research Flow Cytometry Core (RFCC). Sorting was
completed on a BD FACS Aria II flow cytometer with two 96 well tissue culture plates
(single cell per well) (Corning CL 3595) for each of the four color quadrants, in addition
to a polyclonal pool of cells from each color quadrant. Cells were allowed to propagate
and any well with zero or multiple colonies was excluded from further downstream
experiments. Single cell clones from each well were later transferred to 10 cm tissue
culture dishes (Corning 430167). Once the 10 cm dishes were approximately 80%
confluent, the cells were harvested, resuspended in DMEM with 10% FBS and 10%
DMSO, then stored in a -80 °C freezer, with a small amount of cells from each dish being
used for DNA isolation. DNA isolation was performed using an EZNA tissue DNA
isolation kit (Omega Bio-Tek D3396-02) and that purified DNA used in PCR assays.
PCR was performed using Lac-F (5’- CTTCAAATCCGACCCGTAGA-3’) and
TK-R (5’- GTAAGTCATCGGCTCGGGTA-3’) forward and reverse primer set.
PrimeSTAR GXL polymerase (R050A) per manufacturer instructions for a 50 ul reaction
using 120 ng template. Cycling conditions were as follows: denature 98 °C 10 sec,
anneal 57 °C 15 sec, extension 68 °C 1 min for 30 cycles. PCR products were then
purified with EZNA cycle pure kit (Omega Bio-Tek D6492-02) and 20 ul of each
purified product was electrophoresed on a 1% ultra-pure agarose gel (Invitrogen 16500100) to verify size of PCR product.

Flow cytometry
Flow cytometry was performed on the BD Accuri C6 machine. 5 x 105 adherent
cells were trypsinized (Gibco) and centrifuged at 300 x g for 3 minutes. Supernatant was
removed and the cell pellet was resuspended in 300 ul PBS. The cells were centrifuged
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for another 3 minutes at 300 x g. Supernatant was aspirated and cell pellet resuspended
in 200 ul PBS. The number of events was set to 20,000 for gated cells, with flow speed
on medium setting. Color compensation was set at correcting FL2 by subtracting 6.3% of
FL1. The color compensation was determined empirically to minimize spectral overlap
using the DF6 and DF7 cell lines that produce only red fluorescent protein or green
fluorescent protein respectively. A dot plot was used for the FSC-A vs SSC-A plot with
Y-axis (0-16,777,215) and X-axis (0-16,777,215) on linear scale to determine gating out
of debris. A density plot on log scale with FL2-H Y-axis (300-200,000) and FL1-H Xaxis (500-2,000,000) was used for defining the color quadrants. The color quadrants
were determined empirically with the DF6 (red only) and DF7 (green only) cell lines,
including color compensation. X-axis division is at 104.3 and Y-axis division at 103.7
which enables separation of fluorescent colors into defined quadrants.

Western blotting
DF2 treated or untreated cells were lysed with Mammalian Protein Extraction
Reagent (M-PER) (Thermo Scientific 78501) and protease inhibitor cocktail (Sigma
P8340). Cleared whole cell lysates were electrophoresed on an SDS-PAGE gel and
transferred to a polyvinylidene fluoride (PVDF) membrane (ThermoFisher Scientific
88518), membranes were probed overnight using a 1:1000 dilution of primary antibody
against the HA tag on I-Sce1 (Santa Cruz sc-7392 (F7) ), and mouse β-actin (SigmaAldrich A5441). After incubation in corresponding horseradish peroxidase (HRP)
conjugated secondary antibody (1:2000) for 2 hours at RT, membranes were then imaged
on a Fuji LAS-3000 using ImageReader.
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Aphidicolin and hydroxyurea treatments
Aphidicolin (0.2 uM) and hydroxyurea (0.2 mM) were the replication inhibitors
chosen for the experiments performed on the cell lines containing secondary structure
forming sequences. For these experiments, the replication inhibitors were constantly
applied for seven days and the cells were then allowed to recover for four days, before
harvesting and testing for flow cytometry results.

Statistical analysis
For statistical analysis of the flow cytometry experiments the Wright State
University Statistics Center was consulted. All of the data are expressed as mean±SEM.
It was determined that a paired T-test with Bonferroni correction was the most
appropriate method when comparing the four flow cytometry quadrants. P < 0.0125 was
used as the criterion for significance.
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RESULTS
I. Development of a novel model to emulate reversion of a genetic
duplication in Fanconi anemia
Successful creation of a Dual Fluorescence model system in human cells
To help understand the underlying factors involved in AMR, I set out to develop
a cell line that emulates a simplified locus that has encountered AMR. To create the
model cell lines, five experimental DF plasmid vectors were designed and cloned. The
vectors are stably integrated into a HeLa cell line (occurring in more than 74,000
PubMed abstracts), and recent examination of the HeLa genome determined that it is
relatively stable with mutation rates akin to normal tissue, thus providing a high quality
reference genome for research (Adey et al., 2013). The DF cell line designs are based
upon the FA patient that had the partial duplication reversion in the hematopoietic cell
lineage. The Alu elements and partial introns used in the constructs are based on the
sequence of that patient where intron 1 is present only once but intron 6 is present twice
since it is part of the duplication. The design incorporates the use of a rare yeast
endonuclease I-Sce1 that has no known recognition site in the human genome. The
constructs are designed with an I-Sce1 18 bp recognition site so that when I-Sce1 is
expressed in cells containing the DF constructs it will cause a DSB. Another key aspect
of the DNA constructs is the use of fluorescent protein marker genes, so that expression
within the cells can be assayed via flow cytometry. Two control constructs, DF6 and
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DF7, were designed without any patient sequence or I-Sce1 restriction sites and these
were used as positive controls for gating and compensating the flow cytometry
experiments because they contain only a red or a green fluorescent marker gene
respectively (Figure 10).

Recombination is not biased by placement of DSB
DF1, DF2, and DF3 are structured similarly and express both Tomato and eGFP,
with DF1 being a control without an I-SCE restriction site. The individual constructs are
meant to mimic the maternal partial duplication (Figure 11). While it is evident that
reversion of the duplication to WT occurred in the FANCT patient, the mechanism is
unclear. The reversion back to WT in the patient could happen by a break between the
first and second Alu’s or a break between the second and third Alu’s followed by
recombination. An aim of this experiment is to observe if the partially duplicated
FANCT reversion is biased (more likely to occur) depending on whether the DSB occurs
between either the Alu 1/2 segment or the Alu 2/3 segment of the model ectopic locus.
Each fluorescent marker DNA sequence has its own promoter and poly-A signal
for independent transcription. The promoter and poly-A signal for each fluorescent
marker gene is also different to eliminate sequence homology that could be used for
recombination. Characteristic to all DF 1-3 constructs; in order from 5’ to 3’ are an Alu Intron 1 - Tomato - Alu - Intron 6 - eGFP - Alu - Intron 6, the difference between DF2
and DF3 is simply the placement of the I-Sce1 restriction site. Each Alu segment is 311
bp in length and each intervening sequence (IVS) is a partial intron consisting of the first
180 bp of the FANCT patient’s intron. The distance between Alu1/Alu2 is 1715 bp,
Alu1/Alu3 is 3710 bp and Alu2/Alu3 is 1678 bp. DF2 was constructed with the I-Sce1
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Figure 10: Model cell lines with only Tomato or eGFP. These two cell lines do not
contain any Alu elements, intronic sequences or I-Sce1 recognition site and were used
to empirically determine gating of RFP vs GFP quadrants in flow cytometry analysis.
(A) DF6 cell line contains only the Tomato fluorescent marker. (B) DF7 cell line
contains only the eGFP fluorescent marker.
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Figure 11: Model cell lines to determine DSB location bias in recombination.
(A) Schematic of maternal partial duplication in FANCT allele. Arrows are drawn in
the patient genotype indicating where the DSB is induced in the experimental DF cell
lines meant to mimic reversion in the patient. (B) DF1 cell line is a control that does
not harbor an I-Sce1 recognition site and no DSB should occur when I-Sce1 is
expressed. (C) DF2 cells have the I-Sce1 recognition site next to eGFP that is located
between the second and third Alu’s. (D) DF3 cell lines possess an I-Sce1 recognition
site that is adjacent to Tomato and located between the first and second Alu’s.
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restriction site 5’ to the eGFP, so if there is bidirectional 5’ DNA resection and
Alu2/Alu3 recombine, it would eliminate the eGFP signal and only Tomato would be
produced. DF3 has the I-Sce1 restriction site 5’ of the Tomato marker and when I-Sce1
is expressed and bidirectional 5’ DNA resection occurs, then Alu1/Alu2 can recombine to
induce loss of the Tomato marker and the cell will fluoresce green. Another possibility is
that Alu1/Alu3 could recombine and both Tomato and eGFP will be lost, then the cell
would be double negative for fluorescence. These would be the major expected
recombination patterns, but other exotic recombinations and translocations could also
exist. DF1 should not change fluorescence when I-Sce1 is expressed due to a lack of a
restriction site for I-Sce1, therefore it can be used as a control for off-target effects of ISce1 on fluorescence.
If the I-Sce1 induced DSB facilitates recombination leading to a loss of
fluorescent markers, it can be assessed by fluorescence microscopy. The outcome of
DNA repair is a mixed population of cells with various recombination patterns. The
different recombination patterns can be detected by microscopy as indicated by a shift in
fluorescence from double positive (green plus red = yellow). No change in fluorescence
occurred in the DF1 cell line that does not have an I-Sce1 recognition site and that cell
population is primarily double positive which appears as yellow. The DF2 had a shift to
red (consistent with AMR between Alu2 and Alu3), and to a smaller extent to green
(consistent with AMR between Alu1 and Alu2) while also retaining some yellow. The
DF3 cell lines has a large shift to green with some red, while also possessing some
yellow color. Another possibility is loss of both fluorescent color markers (consistent
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with AMR between Alu1 and Alu3 or long range non-HDR) and this can also visualized
in both the DF2 and DF3 cell lines after I-Sce1 expression (Figure 12). These results
indicate that the model is capable of recapitulating the AMR found in the FANCT
patient.
Fluorescence microscopy is sufficient for a quick assay to determine
recombination patterns but a more sensitive and quantitative method is desirable. Flow
cytometry is sensitive and accurate enough to compare ratios of fluorescence between
experimental groups. The TOM (red) fluorescence intensity will be on the FL2 channel
along the Y-axis and the eGFP (green) fluorescence intensity will be on the FL1 channel
along the X-axis. The measurable fluorescent data output will be divided into four
quadrants: double positive = +GFP/+TOM (DP), double negative = -GFP/-TOM (DN),
RFP = -GFP/+TOM (Red), GFP = +GFP/-TOM (Green) (Figure 13).
A flow cytometry time course experiment was performed on the DF2 cell line to
ascertain how long of a recovery period was needed for DNA repair and the subsequent
shift of cells into defined fluorescent quadrants. The recovery time course experiment
reveals that the number of recombinants in each quadrant does not change much from
days 5-8, but rather form tighter groups (Figure 14). In contrast to the flow cytometry
results, the genomic rearrangement occurs at an earlier time point as determined by a
time course PCR. The results from PCR indicate that a majority of recombination events
occur within 48 hours after I-Sce1 transfection (Figure 15).
DF1, DF2 and DF3 cell lines were transiently transfected with I-Sce1 and allowed
to recover for 8 days, at which time cells were harvested and subjected to PCR and flow
cytometry analysis. PCR was used to analyze recombination patterns in DF1, DF2 and
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Figure 12: Fluorescent microscopy reveals a shift in fluorescence in experimental
cell lines after I-Sce1 expression. (A) DF1 cell line remains double positive for TOM
and eGFP (yellow). (B) DF2 cell line has a significant shift from double positive to
red. (C) DF3 cell line shifts significantly from double positive to green.

36

Figure 13:

Flow cytometry determination of recombination by shift in

fluorescence. Cell lines without I-Sce1 transiently expressed will be primarily double
positive and in the top right quadrant. Cells that have lost green fluorescence will shift
from top right quadrant to top left quadrant.

Cells that no longer produce red

fluorescence will move down to bottom right quadrant from top right. Cells that are
absent of both red and green fluorescence will shift from the top right quadrant down to
bottom left.
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Figure 14: A delay in flow cytometry measurement is required. Map of the DF2
ectopic insert (Top). A flow cytometry time course experiment from 1 day to 8 days
post transfection with the I-Sce1 expression vector.

38

Figure 15: Genomic recombination occurs within 48-72 hours. Agarose gel of
PCR products from DF2 cells post I-Sce1 transfection using the Lac-F and TK-R PCR
primers.
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DF3 cell lines to determine if the recombination products are of expected size (Figure
16). Using a forward primer (Lac-F) that binds upstream of the first Alu in the ectopic
sequence and reverse primer (TK-R) that binds the TK domain in the acceptor cell the
full length ectopic site 5373 bp. If there is a DSB and recombination of the proximal
Alu’s, the PCR product will be approximately 3347 bp. Recombination of distal Alu’s
will produce a PCR product of 1352 bp. When I-Sce1 is expressed in the DF2 and DF3
cells it is apparent that there are two smaller recombination products that equate to the
hypothesized AMR products of 3347 bp and 1352 bp, in addition to the full length size
5373 bp PCR product. This is a heterogeneous population so it is expected to observe
both size recombination products. Expression of I-Sce1 in the DF1 cells should not
produce a smaller PCR product since it not does not contain an I-Sce1 recognition site,
and the PCR results indicate this is valid.
Flow cytometry determined, as previously hypothesized, the DF1 cell line did not
change the pattern of fluorescence, with around 99% of total cells double positive (Figure
17). If AMR occurs after an I-Sce1 DSB in the DF2 and DF3 cell lines, then a shift in
cell population fluorescence is expected from double positive to red (DF2) or green
(DF3). The flow cytometry results reveal that after an I-Sce1 DSB, the DF2 cell
population contains 53.1% double positive and 33.8% red fluorescent cells, while the
DF3 cell population contains 54.1% double positive and 30.2% green fluorescent cells.
These data reveal nearly identical AMR recombination patterns between the DF2 and
DF3 cell lines.
The combination of microscopy, flow cytometry, and PCR analysis of DF1, DF2
and DF3 cell lines establishes evidence that the DF system is valid for detection of DSB
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Figure 16: PCR analysis of DF1, DF2 and DF3 cell lines displays distinct
recombination patterns. (A) Map of cell line constructs. (B) (Lanes 2,4,6) Cell lines
without I-Sce1 expression, displaying only the full length PCR product. (Lane 3) is the
DF1 control cell line without an I-Sce1 recognition site. Recombination products can
be observed at the expected sizes after transient I-Sce1 expression in DF2 and DF3 cell
lines (lanes 5,7). (C) Maps of the type of recombination patterns expected which
correlate to PCR products of DF2 and DF3 cells after an I-Sce1 induced DSB when
using the Lac-F and TK-R PCR primers.
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Figure 17: Location of DSB does not affect repair pattern after I-Sce expression.
At the top are cell line maps and flow cytometry pattern expectations. (A) The DF1 cell
line did not exhibit a shift in fluorescence.

(B) DF2 cells predictably migrate

significantly towards red and double negative. (C) DF3 cells shift towards green and
double negative.
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recombination. Additionally, the flow cytometry results indicate that there is not an
AMR recombination bias due to the location of the DSB between different Alu elements.

Presence of upstream Alu element affects recombination pattern
A pending question needing to be addressed was how DSB recombination
patterns would compare between the partial duplication model system (DF1, DF2 and
DF3) and a model system that mimics the WT allele. Therefore, two additional cell lines
were created that model the WT allele (Figure 18). DF4 is a control that does not contain
an I-Sce1 recognition site and DF5 is a construct that harbors the I-Sce1 recognition site.
The DF4 mimics the DF1 cell line and DF5 emulates the DF2 cell line constructs with the
exception of the upstream Alu and IVS 1 removal. DF2 ectopic pattern from 5’ to 3’ is
an Alu – IVS 1 - Tomato - Alu – IVS 6 - I-Sce1 - eGFP - Alu – IVS 6, while the DF5 is
Tomato - Alu – IVS 6 - I-Sce1 - eGFP - Alu – IVS 6. The hypothesis is that the upstream
Alu element present in the DF2, but not DF5 may lend an extra opportunity for HDR
after a DSB and 5’ DNA end resection that will affect recombination patterns.
PCR was used to analyze recombination patterns in DF4 and DF5 cell lines to
determine if the recombination products are of expected size. Using the Lac-F and TK-R
primer set, the full length ectopic site PCR product will be 4882 bp. If there is
recombination of the Alu elements after the DSB then the expected recombinant size is
2887 bp. In the DF4 cell line only the full length PCR product is detectable and the
transient expression of I-Sce1 did not generate any additional recombination products. In
the DF5 cell line without I-Sce1 expression only the full length band is observed. When
I-Sce1 is expressed in the DF5 cells there are two PCR products observed that equate to
the hypothesized AMR product of 2887 bp and the full length size of 4882 bp (Figure
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Figure 18: DF4 and DF5 cell lines emulate patient WT allele. (A) FANCT patient
WT allele. (B) DF4 cell line is the control that does not contain an I-Sce1 recognition
site.

(C) DF5 is the construct that possesses an I-Sce1 recognition site where an

I-Sce1 induced DSB can occur. Both constructs contain only two Alu elements akin to
the FANCT patient WT allele.
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19). Additionally, PCR products from the DF6 and DF7 cell lines were electrophoresed
on the same agarose gel to verify if the PCR products are the hypothesized size of 2600
bp (Figure 19).
Flow cytometry was also used to detect recombination following an I-Sce1
induced DSB in the DF4 and DF5 cell lines. The DF4 does not contain an I-Sce1
recognition site and displayed no difference in the double positive population of cells
(~96%) after I-Sce1 was transiently expressed. In contrast, the DF5 (which contains an ISce1 recognition site) cell line exhibited significant recombination after the I-Sce1
induced DSB with 56.4% in the double positive cell population. Interestingly, the DF5
recombination product percentage was higher in the double negative population (22.6%)
than the red population (14.4%) (Figure 20).
Now that recombination patterns have been established for DF4 and DF5 cell
lines (2 Alu’s), it is pertinent for comparison to the DF2 cell line (3 Alu’s) to address if
the additional upstream Alu in the ectopic locus affects DSB recombination. The number
of double positive cells after an I-Sce1 induced DSB is comparable at 53.1% for DF2 and
56.4% for DF5. The striking observation between the two cell lines is the difference in
the red quadrant 33.8% for DF2 vs 14.4% for DF5 (Figure 21). It appears the majority of
cells have shifted from the red quadrant to double negative in the DF5 cell line (22.5%)
when comparing to the DF2 cells (9.7%), even when accounting for background
differences. Based on the PCR analysis the data indicates that the red quadrant is linked
to homology directed repair. When comparing recombination patterns of the (2 Alu) DF5
cells and the (3 Alu) DF2 cells, the evidence suggests that loss of the upstream Alu1
changes the pattern of recombination. One possible explanation for this phenomena is
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Figure 19: PCR analysis of DF4 and DF5 cell lines demonstrate distinct
recombination patterns. (A) Map of cell line constructs. (B) Cell lines without ISce1 expression, displaying only the full length PCR product (Lanes 2,4). DF4 is the
control cell line without an I-Sce1 recognition site after I-Sce1 expression (Lane 3).
Recombination products can be observed at the expected sizes after transient I-Sce1
expression in the DF5 cell line (lane 5). DF6 and DF7 fluorescent control cell lines are
at expected size (Lanes 6,7). (C) Maps of the type of recombination patterns expected
which correlate to PCR product of the DF5 cells after an I-Sce1 induced DSB when
using the Lac-F and TK-R PCR primers.
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Figure 20: DF4 and DF5 recombination patterns after I-Sce1 expression. At the
top are cell line maps and flow cytometry pattern expectations. (A) DF4 control cell
line does not exhibit recombination due to lack of I-Sce1 recognition site.
(B) DF5 cell line displays considerable recombination after an I-Sce1 induced DSB.
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Figure 21: Loss of Alu1 changes the pattern of recombination: At the top are cell
line maps and flow cytometry pattern expectations. (A) DF2 and (B) DF5 cells before
(top panel) and after I-Sce1 expression (bottom panel).
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that the upstream Alu present in the DF2 cell line provides an extra opportunity for Alu
mediated recombination that could restore the red marker gene. In contrast, the DF5 may
continue resection and subsequent recombination occur on the ectopic FRT sites or
another long range recombination event that eliminates both fluorescent marker genes
and primer binding sites.

FACS analysis and PCR of DF2 cell line reveals unique patterns of
recombination
To further investigate what type of DNA repair mechanism each quadrant
represents, flow assisted cell sorting (FACS) was utilized. FACS is capable of single cell
per well sorting for each quadrant. DF2 cells that have been subjected to I-Sce1
expression were allowed to fully separate and recover. Then the whole population of
mixed recombinant cells was used for FACS. Placing approximately one cell per well
into 96 well tissue culture plates, each of the four quadrants was gated out individually
and sorted. Standard Sanger sequencing of the PCR products from each color quadrant
yielded uninterpretable results because of the mixture of recombinant possibilities from
each quadrant in the sample. By using the FACS method, each individual cell can
proliferate into a population that will yield pure genotypes that then can be subjected to
PCR and sequencing. This will provide information into what type of repair mechanism
would most likely account for the recombinants in each quadrant. The Lac-F and TK-R
primer set was used for PCR of FACS clones.
The double positive quadrant still retains both fluorescent markers as detected by
flow cytometry. I hypothesize that after an I-Sce1 induced DSB the recombinants present
in this quadrant could be produced by: perfect HR, precise re-ligation of break, not cut by
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I-Sce1 or non-homologous end joining (NHEJ). If the proposed mechanisms are
involved, then the FACS clones from the double positive quadrant PCR should all be the
same size with the exception of NHEJ which may be slightly smaller or larger. An
agarose gel of PCR products from the double positive quadrant FACS clones reveals that
8 out of 10 clones produced a PCR product of the expected full length size of 5373 bp.
Clones 4 and 15 are slightly smaller possibly due to NHEJ repair. Sequencing revealed
that the full length PCR products are the exact initial sequence without any deletions. For
clones 4 and 15, there were some smaller deletions biased toward the eGFP marker
(Figure 22).
The red quadrant has lost the eGFP fluorescent marker and now only contains the
TOM marker. The most reasonable explanation for this genomic recombination is
through intramolecular single strand annealing (SSA) or intermolecular unequal
homologous recombination (uHR). With SSA, there would be recombination between
the proximal Alu’s 2 and 3 on the same chromosome which eliminates the TOM
fluorescent marker. Another possibility is uHR which uses the sister chromatid as
template for repair but the upstream Alu 2 on the broken chromatid could use the
downstream Alu 3 as template for repair and skip over the intervening sequence thereby
eliminating eGFP on the repaired chromatid. Both of these repair mechanisms ultimately
lead to a deletion and thereby a reduction in the size of the PCR product. The expected
size of the PCR product after recombination is 3347 bp. PCR of the red quadrant FACS
clones produced products in all 10 samples with no full length size products. All 10 out
of 10 clones were the correct size of 3347 bp for proximal recombination of Alu 2 and
Alu 3 and sequencing confirmed this was the result (Figure 23).
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Figure 22: FACS sorting and PCR of double positive quadrant. (A) Map of ectopic
locus in DF2 cell line with primer binding locations included (blue arrows).
(B) Agarose gel of PCR products from double positive quadrant FACS clones.
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Figure 23: FACS sorting and PCR of red quadrant. (A) Map of ectopic locus in
DF2 cell line with primer binding locations included. (B) Agarose gel of PCR products
from the red quadrant FACS clones. All clones produced a PCR product and 10 of 10
were the expected proximal recombination size. No clones produced a full length
progenitor size PCR product.
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The FACS clones from the double negative quadrant did not display any
fluorescence and are presumed to have lost both TOM and eGFP fluorescent markers.
The most straightforward explanation is that after a DSB at the I-Sce1 recognition site
there is distal recombination between Alu 1 and Alu 3, thereby eliminating the genomic
sequence in between that contains the fluorescent markers. Another possibility is that
resection extended past both the TOM and eGFP sites and a form of microhomology end
joining (MMEJ) has occurred and recombined in the same fashion as NHEJ. The latter
explanation would be consistent with the double negative quadrant in the DF5 cells when
the upstream Alu1 is not present and therefore offers less opportunity for HDR. The PCR
results indicate that the majority of recombinants are not due to recombination of Alu 1
and Alu 3. Out of 8 clones, none produced a full length or proximal Alu recombination
size PCR product. Three clones did not produce a PCR product (clones 3, 29, 40), two
produced distal Alu recombination size products (clones 25, 46), three clones revealed
unexpected size products (clones 27, 36, 44). Sequencing indicated that clones 25 and 46
did undergo distal Alu mediated recombination. Sequencing from the unexpected PCR
products appear to be due to translocation events (Figure 24).
Clones generated from FACS flow cytometry of the green quadrant have lost the
TOM DNA sequence but yet retained the eGFP sequence. By an unknown mechanism,
eGFP is retained while TOM is lost, which is quite unexpected considering the I-Sce1
DSB is proximal to the eGFP. It suggests a possible unidirectional resection toward the
TOM from the I-Sce1 mediated DSB origin or possibly an acentric chromosome
fragment that contains TOM that is subsequently degraded. There is not a hypothesized
size product because using the canonical repair pathway there is no clear path of
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recombination that will lead to these products. Of twelve clones, none produced a full
length size PCR product (5373 bp). Only one clone produced a PCR product at the
proximal Alu recombination size (3347 bp). One clone did not produce a PCR product
(clone 27), four produced products around 3 kb (clones 26, 29, 31, 35), three clones seem
to migrate together near 4.2 kb (clones 25,36,40) and three other clones produced various
size products (Clones 3, 37, 39) (Figure 25). Sequencing reveals that for the PCR
products around 3 kb, there was upstream Alu 1/2 recombination in addition to some loss
of sequence between the I-Sce1 site and the eGFP marker. For the other various size
clones it appears that unexpected rearrangements have occurred.

Summary
This novel DF model system was developed to provide a tool that could lend
insight into which factors play a role in the AMR reversion in the FANCT patient. The
results of the experiments presented in this section provide evidence that the DF model
system can emulate the reversion of a FANCT duplication, in addition to being used as a
possible diagnostic tool for DNA recombination. It was observed that placement of a
DSB on either side of Alu 2 in the maternal duplication models provides the same
opportunity for reversion back to WT without bias. Additionally, when comparing the
effects of a DSB in context of the duplication model (DF2) vs WT model (DF5) it was
observed that the upstream Alu in the duplication model promotes HDR. When
considering known DNA repair pathways it can be hypothesized what type of
recombination may be involved in the cells from each quadrant, but further testing helps
to confirm our hypothesis. By using techniques such as flow cytometry, PCR of
polyclonal recombinant population and FACS single cell clone PCR, the results support
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Figure 24: FACS sorting and PCR of double negative quadrant. (A) Map of
ectopic locus in DF2 cell line with primer binding locations included (blue arrows).
(B) Agarose gel of PCR products from the double negative quadrant FACS clones.
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Figure 25: FACS sorting and PCR of green quadrant. (A) Map of ectopic locus in
DF2 cell line with primer binding locations included (blue arrows). (B) Agarose gel of
PCR products from the double negative quadrant FACS clones.
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the previously stated assumptions on the type of repair that is occurring in the cells from
each quadrant. Those conclusions are: double positive quadrant is a mixture of
homology-dependent and -independent repair, red quadrant is homology dependent
repair, green quadrant reflects homology-independent repair and the double negative
quadrant is homology-independent (primarily) and -dependent repair.

II. DNA repair proteins modulate reversion in FANCT model
To aid in the understanding of what type of DNA repair is involved in the
FANCT reversion, use of the DF2 cell line as a DNA repair reporter system can help
elucidate which DNA repair pathways are involved in the DSB resolution. By impairing
specific proteins involved in either HDR, non-HDR or both forms of repair, any change
in repair pathway after an I-Sce1 induced DSB can be detected in the DF2 cell line by
using flow cytometry to detect a modulation in fluorescence in the same quadrant when
comparing the experimental condition to control condition (RTC).

CtIP and RAD51 promote reversion of FANCT duplication
The reversion of the duplicated allele in the FANCT patient’s hematopoietic cell
lineage was hypothesized to be a homology directed repair event using nearby AluY
elements as a source of homology. The prevailing theory for AMR is that a break occurs,
followed by 5’ resection of the DNA ends which exposes 3’ ssDNA tails that can then
seek homology either intra- or inter-molecularly (Kataoka et al., 2013). The required
resection is governed by CDK dependent protein recruitment which is only active during
S/G2 phases when the sister chromatid donor template is available. In vivo experiments
provide evidence that DNA resection can continue for up to 3.5 kb in both directions
from the DSB, which is within the limits of the DF model system to allow for
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recombination of proximal or distal Alu elements (Ferretti et al., 2013; Tomimatsu et al.,
2014; Zhou et al., 2014).
I chose to inhibit CtIP and RAD51 that act in different steps of homology
directed repair to aid in determining the role of HDR in the FANCT genetic reversion. CTerminal Binding Protein 1-Interacting Protein (CtIP) is at the very upstream segment of
the homology directed repair pathway that begins with resection of DNA 5’ ends
(Takeda et al., 2007). CtIP is a CDK dependent positive regulator of resection that
interacts with the MRN complex (Wang et al., 2013). Previous analysis of PCR and
FACS sequencing of the DF2 cell line recombinants reveal that the red quadrant
recombinants are most likely due to HDR. If CtIP is required for resection, then
inhibition of CtIP in the DF2 model system should decrease the number of events in the
red quadrant. siRNA was used to target and inhibit CtIP in the presence of I-Sce1
expression in DF2 cells to assay for differences in DNA recombination (Figure 26).
Results from this experiment reveal that differences in the red quadrant (64% RTC) and
the double positive quadrant (124% RTC) are significant when comparing siCtIP samples
to siCtrl samples. The double negative and green quadrants were not significantly
different.
RAD51 is involved in an intermediate step in homology directed repair after the
DSB and 5’ DNA resection (Khanna & Jackson, 2001). RAD51 will displace RPA from
3’ ssDNA ends and perform its primary function of strand invasion and identification of
complementary homologous sequences in the sister chromatid (Sung & Robberson,
1995). The expectation is that by inhibiting RAD51, the cell cannot efficiently repair the
I-Sce1 directed DSB by homology directed repair in DF2 cells, which results in fewer
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Figure 26: Flow cytometry of siCtIP treated DF2 cells. (A) Map of ectopic locus in
DF2 cell line. (B) Flow cytometry results of siCtrl (left) and siCtIP (right) DF2 cells 8
days post I-Sce1 transfection. (C) Diagram illustrates the percentage difference in
fluorescent recombinants. (D) Western blot demonstrating CtIP knockdown.
Percentages represent the number of events in siCtIP cells relative to siCtrl cells per
quadrant. All of the data are expressed as mean±SEM. Percentages in red were
determined to be statistically significant by using a paired t-test with Bonferroni
correction. P < 0.0125 vs control.
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events within the red quadrant. Inhibition of RAD51 was achieved by using the chemical
inhibitor RAD51 B02, that disrupts binding to DNA and nucleoprotein filament
formation (Alagpulinsa et al., 2014; Huang & Mazin, 2014), with parallel expression of ISce1. The results in this experiment indicate that there is significant difference between
the red quadrant (49% RTC) and the double positive quadrant (136% RTC) when
comparing the control to the experimental RAD51 inhibition (Figure 27). There were not
statistically significant differences in the double negative or green quadrants.
The knockdown of CtIP and the inhibition of RAD51 function results in a
decrease in the red quadrant, which indicates that CtIP and RAD51 promote the reversion
of the FANCT duplication to WT by homology directed repair.

DNA-PK does not promote FANCT reversion
DNA-dependent protein kinase (DNA-PK) also works towards the upstream
portion of DNA double strand break repair pathway, contributing to non-homologous end
joining (NHEJ). After a DSB there is some competition by the MRN complex (HDR)
and Ku70/80 (NHEJ) for broken DNA ends (Lamarche et al., 2010; Tomita et al., 2003).
After Ku70/80 binds broken DNA ends, the DNA-PK catalytic subunit is activated and
will help recruit Artemis, DNA polymerases μ and λ, XRCC4, DNA ligase IV, and XLF
to the break for completion of NHEJ activities (Pawelczak et al., 2011). Nu7026 is a
potent ATP competitive inhibitor of DNA-PK (Niazi et al., 2014; Willmore et al., 2004)
and was used in conjunction with I-Sce1 on the DF2 cell line. Unlike the CtIP and
RAD51 inhibition experiments, the DNA-PK inhibitor treatment did not affect the red
quadrant. There was a significant decrease of cells present in the double negative (65%
RTC) and green quadrants (76% RTC), in addition to an increase in the double positive
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Figure 27: Flow cytometry of RAD51i treated DF2 cells. (A) Map of ectopic locus
in DF2 cell line. (B) Flow cytometry results of control (left) and RAD51i (Rad51 B02
10 uM) treated (right) DF2 cells after I-Sce1 expression. (C) Diagram illustrates the
percentage difference in fluorescent recombinants. Percentages represent the number
of events in RAD51i cells relative to control cells per quadrant. All of the data are
expressed as mean±SEM. Percentages in red were determined to be statistically
significant by using a paired t-test with Bonferroni correction. P < 0.0125 vs control.
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quadrant (120% RTC) (Figure 28). The lack of a statistically significant change in the red
quadrant when impairing DNA-PK suggests that DNA-PK is not involved in the
homology directed reversion of the FANCT duplication to WT, but rather promotes DSB
repair in a homology independent manner.

ATM affects both HDR and non-HDR events
Ataxia Telangiectasia Mutated (ATM) protein exhibits protein kinase activity. In
addition to checkpoint control, ATM is also significantly involved in repair of DNA
double strand breaks. ATM is needed for full activation of DNA-PK activity to
efficiently recruit DNA termini processing proteins required for NHEJ completion (Chen
et al., 2007; Jiang et al., 2015). ATM is also required for successful repair of DSB by
homologous recombination. After the DSB, ATM is needed to phosphorylate members
of the MRE11-RAD50-NBS1 complex (MRN) that initiate the cascade of events to repair
the DSB by homology directed repair (Gatei et al., 2000; Lavin et al., 2015; Uziel et al.,
2003). Caffeine is an inhibitor of ATM protein kinase activity (Blasina et al., 1999) and
was used in conjunction with transient expression of I-Sce1. Ku-60019 is a potent
inhibitor of ATM, that ablates autophosphorylation and ATM activation(Golding et al.,
2009), and was additionally used because of its high selectivity to help further
differentiate ATM’s role in DSB repair.
Flow cytometry analysis of the caffeine treated DF2 cells results in a decrease of
the red (76% RTC), double negative (56% RTC), and green (73% RTC); while double
positives increased (133% RTC). In the KU-60019 inhibitor treated DF2 cells, the results
are red (50% RTC), double negative (64% RTC), and green (80% RTC) as these
quadrants display a decrease in percentages. Meanwhile, the double positive quadrant is
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Figure 28: Flow cytometry of DNA-PKi treated DF2 cells. (A) Map of ectopic locus
in DF2 cell line. (B) Flow cytometry results of control (left) and DNA-PKi (Nu7026
10 uM) treated (right) DF2 cells after I-Sce1 expression. (C) Diagram illustrates the
percentage difference in fluorescent recombinants. Percentages represent the number
of events in DNA-PKi cells relative to control cells per quadrant. All of the data are
expressed as mean±SEM. Percentages in red were determined to be statistically
significant by using a paired t-test with Bonferroni correction. P < 0.0125 vs control.
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increased (149% RTC) (Figure 29). The trends appear to be the same between the
caffeine and the KU-60019 samples with the exception of the red quadrant in the Ku60019 treated cells which has a significantly lower percentage than the caffeine treated
cells, possibly attributed to Ku-60019 being more potent inhibitor of ATM. The results
displayed in this section suggest that ATM promotes the reversion of the FANCT
duplication to WT by homology directed repair. Additionally, it is observed that ATM
also affects homology independent repair as displayed by the reduction in cells present in
the double negative and green quadrants after inhibition of ATM function.

FANCT is involved in HDR and non-HDR events
The Fanconi anemia repair pathway is composed of at least 18 proteins (FANCAFANCT), whose concerted effort can repair some forms of DNA damage. For proteins to
be defined in the Fanconi anemia pathway, the patient cells are subjected to DNA
interstrand cross-linking agents such as MMC or cisplatin and assayed for chromosome
instability when compared to healthy patients (Pinto et al., 2009; Stoepker et al., 2015).
FANCT, a UBE2T ubiquitin conjugase, is known to be required for resolution of
interstrand crosslinks as part of the FA pathway, but participation in other DNA repair
pathways is not yet known.
To determine the effect of FANCT depletion on DNA recombination after an ISce1 induced DSB, experiments were performed in both the U2-OS DR-GFP and DF3
cell lines. Additionally, these experiments will evaluate how well the newly developed
DF model system can determine HDR when compared to the well-established DR-GFP
system by comparing the shift in GFP fluorescence as detected by flow cytometry. The
Hanenberg lab developed stable cell lines which eliminated the function of endogenous
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Figure 29: Flow cytometry of ATMi treated DF2 cells. (A) Map of ectopic locus in
DF2 cell line. (B) Flow cytometry results of control (left), ATMi (right) treated DF2
cells after I-Sce1 expression.

(C) Diagram caffeine (left) and Ku-60019 (right)

illustrates the percentage difference in fluorescent recombinants relative to control cells
per quadrant. All of the data are expressed as mean±SEM. Percentages in red were
determined to be statistically significant by using a paired t-test with Bonferroni
correction. P < 0.0125 vs control.
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FANCT by using CRISPR technology. All results in the U2-OS cell lines are after ISce1 expression under different experimental conditions. The term “no treatment” is
simply the naïve state without CRISPR knockout or complementation. The other 6
experimental conditions have Cas9 nuclease stably integrated and constitutively
expressed. The G2.2 is an sgRNA that targets the endogenous FANCT locus and
“knocks out” the protein. Complementation experiments were performed with stable
integration of a functional FANCT or the control (empty vector) EV plasmid which is the
backbone in the functional FANCT plasmid (Figure 30). Values represent the percentage
of GFP+ cells in experimental (columns 2-7) relative to control (RTC) naïve cell lines
(column 1). The results indicate that there is significant reduction in HDR when
compared to control (column 1) for FANCT null or FANCT null complemented with
(empty vector) EV (columns 2&3). When FANCT null cells were complemented with
FANCT (column 4) the HDR efficiency was restored to near normal levels. The CAS9
lentivirus (LC) alone (column 5), LC + EV (column 6) and LC + FANCT (column 7) cell
lines were used as controls to assure results are due to only the FANCT knockout.
The DF3 cell line was analyzed by flow cytometry after I-Sce1 expression and the
overall pattern of recombination was different between the FANCT+ and FANCT null
cell lines (Figure 31). There was not a significant difference in the red quadrant RTC. In
contrast, there is significant difference when observing the double positive, double
negative and green quadrants RTC. When comparing the results of the DR-GFP system
with the DF3 cell lines the GFP+ percentages are relatively close to each other (Figure32)
when compared to their relative controls. This indicates that the DF3 recombination
system is comparable to the widely used DR-GFP system in terms of HDR that is
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Figure 30: FANCT is involved in HDR. Values represent the percentage of GFP+
in experimental cells relative to control (RTC) naïve (column 1) U2OS cell lines.
There is significantly less HDR in the FANCT null (column 2) and FANCT null + EV
(column 3) than in all other experimental cell lines. The G2.2 FANCT knockout was
then complemented by FANCT and HDR is restored to near naïve conditions (column
4). The presence of the CAS9 alone (column 5) or complemented with EV or FANCT
(columns 6 & 7) did not reduce HDR levels relative to the naïve cell line. The data are
presented as mean±SEM. Paired t-test was used for statistical analysis. * = P ≤ 0.05.
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Figure 31: FANCT maybe involved in HDR and non-HDR events. All results are
after an I-Sce1 induced DSB break in DF3 cells. (A) Map of DF3 construct. (B)
Results of each of four quadrants comparing the DF3 FANCT null cell lines vs.
FANCT+ control per quadrant. The data are presented as mean±SEM. Paired t-test
was used for statistical analysis. * = P ≤ 0.05, ** = P ≤ 0.01.
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Figure 32: Comparable percentage of GFP+ recombinants in FANCT null model
systems. (A) Western blot demonstrating CRISPR knockout of UBE2T (FANCT) in
DF3 and U2-OS DR-GFP cells. (B) Summary slide displaying the percentage of GFP+
cells RTC in the well-established U2-OS DR-GFP system (column 1) is comparable to
the novel DF3 system (column 2) in FANCT null cells.
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detected after anI-Sce1 induced DSB break. In addition, the DF3 model system has the
capability to monitor other forms of DNA repair undetected in the DR-GFP system, such
as: SSA, NHEJ and MMEJ.

Summary
The DF cell lines were constructed to provide insight into what DNA repair
factors are involved in the FANCT reversion in the patient. This system can now be
expanded past the question of what happens in the FANCT patient and be used to assess
DNA repair more generally. Assessing the effects of inhibiting DNA repair proteins in
the DF3 cell line reveals that each quadrant has the ability to report different types of
repair outcomes, when compared to previous findings in literature. Comparison of the
well-established DR-GFP HDR reporter to the DF3 cell line reveals nearly the same
amount of reduction in HDR efficiency when FANCT is not present (~40% reduction).
The DF3 cell lines have the novel ability to identify additional forms of repair, when
compared to the DR-GFP system,that can be attributed to the system design.

III. HDR is reduced when a DSB occurs adjacent to a DNA secondary
structure forming sequence
Microsatellites are repetitive DNA sequences that have the potential to be
mutagenic and promote genomic instability (Bhargava & Fuentes, 2010; Brandström et
al., 2008; Mirkin & Mirkin, 2007b). FANCA, BHDS and GT diseases all have a subset
of patients where the mutagenesis can be attributed to a large AMR. Additional patients
in each of the three diseases presented a different molecular etiology where a small
insertion or deletion occurred around a microsatellite motif sequence located between
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two Alu sequences (Benhammou et al., 2011; Gregory et al., 2001; Levran et al., 1997; Li
et al., 1993). It is therefore reasonable to question if microsatellite sequences have the
potential to induce DNA damage and/or affect DNA break repair. Previous studies have
concluded that microsatellite sequences have the potential to expand or contract when the
replicative polymerases are stalled with aphidicolin (Aph) or hydroxyurea (HU), but it is
not definitive that the instability is due a microsatellite induced break in humans (Kim,
Pytlos, & Sinden, 2006; Sinden et al., 2002). In this chapter, DF3 cell lines containing
DNA secondary structure forming sequences were created to help address the
microsatellite induced break and repair modulation questions. The DF microsatellite
system provides a novel way of testing for microsatellite induced damage and repair in
human cells by a shift in fluorescence. The experiments in this section will determine
how repetitive DNA sequences influence Alu mediated homology directed repair.

Creation of model cell lines
This project utilized CTG/CAG trinucleotide (TNR) or a polypurinepolypyrimidine (Pu-Py) DNA sequence as template for secondary structure forming
motifs. Our lab confirmed that an ectopic cell line containing a microsatellite with 102
CTG/CAG repeats and an upstream c-Myc replicator resulted in instability when
challenged with replication inhibitors. Nascent strand abundance assays reveal that a
select c-Myc sequence can initiate replication (Malott et al., 1999). The proximity of the
c-Myc replicator to the TNR was also found to be imperative for instability in previous
studies, therefore it will be included in this experimental framework (Liu, Chen, et al.,
2012).
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The DF3 construct was modified by adding the c-Myc replicator upstream of the
first Alu sequence. Subsequently, the secondary structure forming sequences were placed
into the original I-Sce1 recognition site that is kept intact at the 3’ end of insert (Figure
33). The sequences used in the TNR model system are a 100 CTG and an 84 CAG triplet
repeats. The length of both of these repeats are large enough to have a propensity for
instability (Brook et al., 1992). The secondary structure forming sequences used in the
triplex model system are an 88 bp mirror repeat that is an asymmetric homogenous
polypurine (TR) or polypyrimidine (TF) sequence. The construct name indicates which
sequence (CTG, CAG, TF or TR) is used as template for lagging strand synthesis relative
to the c-Myc origin. This allows for determination if replication polarity may also affect
repeat instability (Figure 34).

DNA repair is not detected in replication challenged model cell lines
One reason that the specific ectopic repeat sequences were placed into the DF3
cell line system was to determine if there will be a modulation in fluorescence above the
baseline c-Myc only construct. A modulation could potentially occur either
spontaneously or induced by replication inhibitors. If the repeat sequence induces a DNA
break and results in deletion of the DNA sequence containing a fluorescent marker, it can
be detected by flow cytometry. There was not a detectable spontaneous drift of the
control cell line fluorescence over the course of 3 months’ time.
In addition to surveillance of spontaneous fluorescence shift, all five model cell
lines (Myc only, CTG100, CAG84, TR, and TF) were treated with 0.2 uM aphidicolin or
0.2 mM hydroxyurea replication inhibitors to investigate if a DNA break and subsequent
recombination is detected. The replication inhibitors were constantly applied to cells for
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Figure 33: Creation of repeat containing model cell lines. (A) The previously
described DF3 cell line was modified by the addition of (B) a c-Myc core replicator
core and a DNA sequence motif possessing the propensity of forming a DNA secondary
structure (CTG100 is used in this example).
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Figure 34: Repeat motif model cell lines used. All cell lines in this chapter have a
c-Myc core replicator integrated into the ectopic sequence and the nomenclature
represents what sequence is in the lagging strand when replicated from the c-Myc origin.
(A) Myc only contains only the c-Myc core replicator without any repeat sequence.
(B) CTG100 contains 100 CTG triplets. (C) CAG84 contains 84 CAG triplets. (D) TR
contains an 88 bp homopurine sequence and (E) TF contains an 88 bp homopyrimidine
sequence.
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seven days and then given four days after replication inhibitor treatment to recover before
the flow cytometry was performed. The four days post treatment recovery allows the
cells to return to the normal replication cycle and provides time for separation of cells
into flow cytometry quadrants based upon cell fluorescence. The Myc only cell line is to
be used as a baseline since it does not contain a downstream ectopic repeat sequence.
The results demonstrate that in the presence of aphidicolin or hydroxyurea there is not a
considerable shift in fluorescence from the double positive (red + green) population
(Figure 35), indicating the absence of replication stress-induced breakage and
recombination when compared to untreated cells.
The CTG100 and CAG84 cells lines were next subjected to the 0.2 uM aphidicolin
or 0.2 mM hydroxyurea replication inhibitors. The CTG and CAG triplets in this
expanded range are believed to form secondary structures in vivo (Liu et al., 2010;
Sinden et al., 2002). The replication inhibitors foster a slowing of the replicative
polymerase which facilitates the presence of more ssDNA at the replication fork, since
the helicase is not impeded. The increase in ssDNA is predicted to afford more
opportunity for the intramolecular secondary structures to form (Yang et al., 2003). The
formation of secondary structures can lead to genomic instability by increasing DNA
damage and breaks. It is therefore intuitive that in the ectopic cell lines containing the
repeat sequences, there would be increased DNA breaks, and recombination that is
detectable by a shift in fluorescence. Contrary to this hypothesis, the results did not
display a considerable shift in fluorescence of the CTG100 and CAG84 cells lines when
compared to baseline control (Figures 36 and 37). The lack of fluorescence shift may be
attributed to an absence of DNA breakage. Alternatively, there could DNA breakage at
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Figure 35:

Treatment of DF3 Myc cell line with replication inhibitors.

(A) Diagram of ectopic insert present in the DF3 Myc stable cell line (B) Graphical
representation of recombinant fluorescence outcomes in each quadrant. (C-E) Flow
cytometry results of näive, aphidicolin and hydroxyurea treated cells, respectively.
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Figure 36: Treatment of DF3 Myc CAG84 cell line with replication inhibitors.
(A) Diagram of ectopic insert present in the DF3 Myc CAG84 cell line (B) Graphical
representation of recombinant fluorescence outcomes in each quadrant. (C-E) Flow
cytometry results of näive, aphidicolin and hydroxyurea treated cells, respectively.
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Figure 37: Treatment of DF3 Myc CTG100 cell line with replication inhibitors.
(A) Diagram of ectopic insert present in the DF3 Myc CTG100 cell line (B) Graphical
representation of recombinant fluorescence outcomes in each quadrant. (C-E) Flow
cytometry results of näive, aphidicolin and hydroxyurea treated cells, respectively.
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the repeated sequence that fails to repair, forming an acentric chromosome (Luzhna et al.,
2013; Mateuca et al., 2006) containing no fluorescent marker genes. The fluorescent
marker genes would then reside on the centromere side of the break.
Concomitant with the DF3 Myc TNR cell lines, the DF3 Myc TR and TF were
also exposed to 0.2 uM aphidicolin and 0.2 mM hydroxyurea replication inhibitors. The
expectation is much like the DF3 CNG cell lines, that when the replicative polymerase is
slowed down by inhibitors it can facilitate uncoupling of the replication fork, because the
helicase is unaffected. This will allow increased ssDNA at the replication fork that has
the potential to form intra/inter-molecular DNA secondary structures in vivo. This opens
the question of whether the secondary forming structures innately possess the ability to
facilitate DNA breaks especially under replicative stress. Additionally, it is unknown
how a dsDNA break within a secondary forming sequence, such as a triplex, would affect
DNA repair. The DF3 Myc TF and TR cell lines can address these questions by placing
the secondary forming sequence between Alu elements. This design allows for detection
of a shift in fluorescence by flow cytometry, if recombination of Alu elements has
occurred. Contrary to this line of reasoning, the results did not display a considerable
shift in fluorescence of the TF and TR cells lines when compared to baseline control
(Figures 38 and 39). The reason for the lack of fluorescence shift could be from the
same factors outlined previously in the DF3 CNG section, such as formation of an
acentric chromosome.
An additional cell line was created to add some possible insight to why a shift in
fluorescence was not observed in the DF3 microsatellite cell lines. The DF3
microsatellite cell lines have the microsatellite sequence upstream of both fluorescent
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Treatment of DF3 Myc TF cell line with replication inhibitors.

(A) Diagram of ectopic insert present in the DF3 Myc TF cell line (B) Graphical
representation of recombinant fluorescence outcomes in each quadrant. (C-E) Flow
cytometry results of näive, aphidicolin and hydroxyurea treated cells, respectively.
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Figure 39:

0.2 mM HU

Treatment of DF3 Myc TR cell line with replication inhibitors.

(A) Diagram of ectopic insert present in the DF3 Myc TR cell line (B) Graphical
representation of recombinant fluorescence outcomes in each quadrant. (C-E) Flow
cytometry results of näive, aphidicolin and hydroxyurea treated cells, respectively.
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marker genes and an unrepaired break would leave both fluorescent marker genes
together and thereby still have the potential to express both RFP and GFP. The DF2
CTG100 cell line was created to place the microsatellite sequence between the fluorescent
markers, and an unrepaired break at the microsatellite sequence would leave the potential
that only one fluorescent protein is expressed and thus a shift in fluorescence can be
observed. Since the ectopic site is targeted by FLP recombinase we are assured this
ectopic cell line is in the same orientation and location as the DF3 microsatellite cell
lines. The orientation was also confirmed by PCR after integration and selection. The
DF2 CTG100 cell line was subjected to the same regimen of aphidicolin (0.2 uM) and
hydroxyurea (0.2 mM) for seven days and then four days recovery. The results were
dramatically different than the DF3 microsatellite cell line results. The DF2 cell line is
expected to lose eGFP and cells drift from the double positive to the red quadrant. If the
proposed theory of acentric chromosome is valid in the DF2 CTG100 model, the outcome
of the replication inhibitor experiments should be a shift to green fluorescence due to the
eGFP being still linked to the centromere. The result of replication inhibitor treatment is
a dramatic shift toward the green quadrant for both aphidicolin and hydroxyurea treated
cells. These results provide supporting evidence toward the formation of an acentric
chromosome that will lose the Tom gene, but retain the eGFP gene (Figure 40).

Secondary structure forming sequences adjacent to a DSB modulate HDR.
The same five cell lines used in the replication inhibitor studies DF3- (Myc only,
CTG100, CAG84, TR, and TF) will also be used for this experiment. Whilst the previous
experiments focused on a spontaneous or replication inhibitor induced break, this
experiment utilized the I-Sce1 enzyme to induce a DSB at the I-Sce1 recognition site
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Figure 40: Replication inhibitors induce recombination in DF2 CTG100 cell line.
(A) Map of the DF2 CTG100 construct. (B) Expected outcomes of flow cytometry
quadrants. (C) Control without replication inhibitors. (D) Treatment with 0.2 uM
aphidicolin. (E) Treatment with 0.2 mM hydroxyurea.
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located immediately adjacent to the secondary structure forming sequence in the ectopic
insert. Unlike the replication inhibitor experiments that could produce a DSB anywhere
within the secondary structure forming sequence, the I-Sce1 induced break experiments
will result in a DNA break at a specific location immediately juxtaposed to the secondary
structure forming sequence. The reasoning behind this round of experiments is that the ISce1 enzyme will induce a DSB at the recognition site, followed by bi-directional 5’
DNA resection that could be impeded by the secondary structure forming sequence itself
or proteins associated specifically to microsatellites regions. This modulation in
recombination can be assayed in the DF system when comparing fluorescence of
experimental cell lines to the control. The expectation is that there would be fewer GFP+
and double negative recombinants if resection is impeded due to the Alu mediated
recombination obstruction. Previous work has demonstrated that structure forming Arich sequences, from a common fragile site, block repair (Burrow et al., 2010; Wang et
al., 2014). The results support the assumption as fewer double negative and GFP+
recombinants are detected in the A84, T100 (Figure 41) and TF, TR (Figure 42) cell lines
relative to the DF3 Myc controls. RFP+ recombinants are not expected due to the
placement of the I-Sce1 recognition site upstream of the Tomato marker gene.

Summary
The experiments performed in this section aim to determine the influence DNA
secondary forming sequences can have on DNA breaks, recombination and repair. The
DF3- (Myc, CTG100, CAG84, TR, and TF) cell lines that were subjected to replication
inhibitors exhibited no shift in fluorescence when compared to the Myc only control cell
line, suggesting that the secondary forming sequences do not possess increased sensitivity
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Figure 41: TNR sequences juxtaposed to an I-Sce1 DSB reduces HDR. Flow
cytometry results of the TNR containing cell lines CAG84 (A84), CTG100 (T100)
relative to the DF3 Myc control (c-myc only) cell line for the (A) double negative and
the (B) GFP+ quadrants. The data are presented as mean±SEM. Paired t-test was
used for statistical analysis. ** = P ≤ 0.01.
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Figure 42: Triplex forming sequences juxtaposed to an I-Sce1 DSB reduces HDR.
Flow cytometry results of the triplex forming sequence containing TF and TR cell lines
relative to the DF3 Myc control (c-myc only) cell line for the (A) double negative and
the (B) GFP+ quadrants. The data are presented as mean±SEM. Paired t-test was used
for statistical analysis. ** = P ≤ 0.01.
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to DNA breaks in the presence of replication inhibitors. Upon further evaluation, it is
possible that the microsatellite containing DF3 model system design may not be able to
detect DNA breaks because of the fluorescent markers’ gene positioning, relative to
microsatellite sequences. Indeed, the flow cytometry results of the DF2 Myc T100 cell
line with replication inhibitors, suggests that there may be DNA breaks occurring in the
DF3 repeat models but that it is not detected due to system design. If the DNA breaks
occurring at satellite sequences are recalcitrant to repair, it could result in an acentric
chromosome fragment. The DF3 cell line designs have the secondary forming sequences
upstream of the fluorescent marker genes, leaving them linked on the centromeric
chromosomal segment. The DF2 Myc T100 cell line is designed so that the satellite
sequence interrupts the fluorescent marker genes. In this case, after an unresolved DNA
break at the satellite sequence, the Tom gene could segregate with an acentric
chromosome fragment and only the eGFP gene replicate after mitosis.
A decrease in recombination was observed in the DF3- (CTG100, CAG84, TR, and
TF) cell lines when compared to the DF3 Myc control, when extrinsically facilitating a
DNA break. For these experiments, I-Sce1 was expressed in the multiple cell lines and
targets the I-Sce1 recognition site juxtaposed to the secondary structure forming sequence
present in the ectopic segment. This will produce a break that may capable of eliciting
recombination and a shift in fluorescence in the model cell lines. The results indicate a
decrease in homology and non-homology directed DNA repair within the cell lines
containing the secondary forming sequences, when compared to the DF3 Myc control
cell line, after an I-Sce1 directed DNA break. These results suggest that in human cells,

87

DNA secondary structures can inhibit DNA recombination after a DSB near a
microsatellite motif.
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DISCUSSION
The data presented here suggest that the novel DF model system can be used for
detecting DNA repair patterns. By comparing the percentage of HDR repair after a DSB,
it became clear that the novel DF system could closely recapitulate the well-established
U2-OS DR-GFP system. With impairment of DNA repair proteins involved in decided
repair fates, it was possible to indirectly define the recombination outcomes for the DF
system flow cytometry quadrants. FANCT, a UBE2T ubiquitin conjugase, was recently
discovered to be involved in Fanconi anemia when deficient. This discovery established
FANCT’s importance in resolving interstrand crosslinks via the FA pathway, FANCT’s
involvement in other types of DNA repair is unknown. The U2-OS DR-GFP system was
used to define the effect FANCT has on HDR after an I-Sce1 directed DNA break.
FANCT was also impaired in the DF system and yielded quantitatively similar HDR
results, in addition to information about other types of DNA repair that FANCT may
influence. Lastly, by adding microsatellite sequences to the DF system, it provides a
novel model system to test the effects non-canonical DNA structures can exert on either
producing DNA strand breaks or influencing which repair pathway is utilized in human
cells.

Novel DF model system can emulate the genomic reversion displayed in
FANCT patient cells
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The primary reasoning for developing the DF model system was to elucidate
factors involved in the FANCT genomic rearrangements of hematopoietic cells present in
a FANCT patient. The reversion of the FANCT maternal duplication in the FA patient is
thought to occur from the homology directed repair of a DNA break that utilizes the
nearby Alu elements for recombination. DF (1-3) cell lines were created to emulate the
partial duplication found in the maternal allele. It is hypothesized that the partial
duplication was reverted back to WT as a result of an HDR event using the Alu elements
as template. An outstanding question is whether there is a recombination bias when all
three Alu elements are present within the locus. Therefore, an I-Sce1 recognition site
was placed downstream of the central Alu in the DF2 cell line and upstream in the DF3
cell line. Since the reversion to WT could occur by a break and recombination on either
side of the central Alu our goal was to determine if there is a bias to one side.
The results indicate that there is nearly the same opportunity for a proximal Alu
mediated deletion event on either side of the central Alu element when comparing the
recombination pattern of the DF2 and DF3 cell lines by flow cytometry. This indicates
that the initial break that induced the patient hematopoietic cell back to WT FANCT
could have occurred between either Alu1/2 or Alu2/3 and repaired with close to the same
efficiency. DF4 and DF5 cell lines were created to determine if the WT deletion in the
FANCT patient’s paternal allele occurs with the same efficiency as a deletion in the
duplication model. DF2 and DF5 are the exact same ectopic sequence except for removal
of the upstream Alu element in the DF5 cell line. Following an I-Sce1 induced DNA
break in DF2 and DF3 experimental cell lines, there are approximately 53-56% cells
remaining in the double positive population. It would therefore be plausible to expect the
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same amount of proximal Alu mediated recombination between the DF2 and DF5 cell
lines. Surprisingly, there was less than half the amount of proximal Alu mediated
recombination in the DF5 model when compared to the DF2 cell line results.
Additionally, there was a sharp increase in the double negative population of the DF5
cells. This would indicate that there is less proximal AMR and a shift towards a
presumable non-HDR event when the upstream Alu is not present. In summary, the
results of this section provide evidence that a reversion of the nonfunctional partially
duplicated maternal allele back to a functional WT allele is more likely than the
conversion of a WT allele to a FANCT deleted paternal allele.

Analysis of the DF2 cell line reveals unique patterns of recombination
The original hypothesis of what type of DF2 cell line recombinants would be
present in each flow cytometry quadrant was that the RFP quadrant would reflect
proximal Alu recombination and the double negative quadrant would reflect distal Alu
recombination. There were no expectations for the GFP quadrant, as there is no
canonical repair mechanism to recombine and lose red fluorescence but not green
fluorescence. The remaining double positive quadrant population were expected to
comprise of; no DNA break, precise re-ligation, perfect HR repair or NHEJ (Kühne et al.,
2003; Lin et al., 1999; Vu et al., 2014). Unexpectedly, there was a small population of
green cells detected by flow cytometry. This led to a need to further analyze the different
quadrants and obtain a more detailed picture of what type of recombination is present in
each quadrant. Sequencing and classical PCR could not be used to answer this question
because of the heterogeneity of the cell population. It was decided to use FACS to
process the recombinant cell population by single cell sorting for each quadrant. By
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using this technique, it was possible to propagate each individual clone and have enough
cells for further assays. This made it possible to have pure populations that could then be
used for PCR and DNA sequencing to provide insight as to what type of recombination is
present in each quadrant.
A random selection of single cell clones from each quadrant were next subjected
to PCR analysis to first determine if a PCR product could be detected. The upper PCR
primer was located at the upstream portion of the ectopic sequence and the lower PCR
primer was located in the TK portion of the acceptor cell line DNA. The PCR results
from 10 single cell sorted clones of the red quadrant all produced a product of expected
size if proximal Alu recombination had occurred. Sequencing revealed that the
recombinants had undergone a proximal Alu mediated recombination. This validates that
the DF system can recapitulate the reversion witnessed in the FANCT patient cells. The
double positive quadrant contained homology and non-homology directed repair
outcomes. For the double negative and green quadrants, there was a mix of wild-type
and unanticipated (deletions and inversions) PCR products as detected by DNA
sequencing. Thus, although the major pathways of DSB recombination have been
deduced, our results show a much greater complexity of recombination outcomes when a
single chromosome locus was monitored.

Impairment of DNA repair proteins CtIP and Rad51 confirm red quadrant
recombinants are due to an HDR event
To further examine factors impacting a genetic reversion, canonical DNA repair
proteins that are involved in specific types of repair were disrupted and the modulation of
flow cytometry patterns analyzed. To test the effect that homology directed repair plays
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in FANCT reversion, it was decided to decrease the activity of two HR proteins, CtIP and
Rad51. CtIP is vital for initiation of 5’ DNA resection that is required for homology
directed repair and works at the beginning of the HDR process (Polato et al., 2014;
Takeda et al., 2007). Rad51 is also vital to HDR and is involved in the middle step of the
repair process by assisting with homology search and donor template strand invasion that
is required for homologous recombination (San Filippo et al., 2008; Sung et al., 1995).
Impairment of either of these proteins should reduce HDR and the expectation is it will
reduce the number of recombinants present in the red quadrant after an I-Sce1 directed
DNA break. The results reveal that inhibition of both CtIP and Rad51 reduced the
number of red quadrant recombinants to 64% and 49% relative to control, respectively.
In combination with the PCR and sequencing results of red quadrant recombinants, these
results provide evidence that the DF system is capable of detecting the HDR events
responsible for the FANCT reversion in patient cells.

Inhibition of DNA-PK confirms that double negative and eGFP quadrant
recombinants are primarily derived from non-homology dependent repair
events
The PCR and sequencing results from the FACS clones for the double negative
and eGFP quadrants indicate that those quadrants primarily represent non-HDR events.
Inhibition of a DNA repair protein known for its involvement in NHEJ was chosen to
further examine the validity of that hypothesis. DNA-PK is immediately recruited to a
DSB in vivo (Uematsu et al., 2007). DNA-PK binds the broken DNA ends and then
facilitates recruitment of additional DNA processing enzymes to complete repair in a
non-homology mediated manner (Davis et al., 2013; Pawelczak et al., 2011b). The result
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of inhibiting DNA-PK concomitant with an I-Sce1 directed DNA break was a decrease in
double negative and eGFP recombinants to 65% and 76% relative to control. The results
of PCR, sequencing results and NHEJ inhibition provide validity that the double negative
and eGFP flow cytometry quadrants represent recombinants derived primarily from nonHDR events.

DF system is capable of detecting homology dependent and non-homology
dependent repair events simultaneously
The previous experiments have displayed the ability of the DF system to detect
homology dependent or non-homology dependent events independently, but to reach full
potential as model system of DNA recombination it must be capable of detecting both
types of repair events simultaneously. The protein kinase ATM was targeted for
inhibition as a means of achieving this goal. ATM works soon after a DNA break and is
needed for phosphorylation and activation of both CtIP and DNA-PK (Jiang et al., 2015;
Wang et al., 2013). For ATM inhibition purposes, caffeine and an ATM specific
inhibitor were used. Caffeine inhibits ATM function but it is not just specific to ATM
and also affects other protein kinases, such as ATR (Sarkaria et al., 1999). The result of
using caffeine to inhibit ATM was a decrease of recombinants in the red, double negative
and eGFP quadrants by 24%, 44% and 27%, respectively. Since caffeine is promiscuous
to other protein kinases, a very specific inhibitor of ATM was also independently used.
That experiment also resulted in a decrease of recombinants in the red, double negative
and eGFP quadrants by 50%, 36% and 20%, respectively. While both methods of
inhibition resulted in a decrease of both homology dependent and non-HDR events, the
more specific inhibition of ATM appears to preferentially affect the red quadrant and
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homology directed repair. The greater reduction of non-HDR events in the caffeine
experiment could be attributed to an inhibition of another protein kinase outside of ATM
that is preferentially involved in non-homologous repair. The results of this experiment
confirm that the DF system is capable of detecting homology dependent and nonhomology dependent repair events simultaneously.

The repair pattern of the double positive recombinants was not determined
under DNA repair inhibition conditions
An issue not yet addressed is why the double positive quadrant recombinants
increase after DNA repair protein inhibition regardless of homology dependent or nonhomology dependent event targeting. PCR and sequencing result analysis of the double
positive quadrant recombinants were performed after an I-Sce1 directed DNA break, but
under normal repair conditions. The expected recombinants in the double positive
quadrant are; no break occurred, precise re-ligation with no DNA end processing, perfect
HR and limited NHEJ or MMEJ. The PCR and sequencing results indicate that either no
break occurred, precise re-ligation with no DNA end processing or perfect HR outcomes
predominate with a minority of non-homology dependent events (i.e. NHEJ). It can be
assumed that the amount of I-Sce1 digestion is comparable under different experimental
conditions considering that the standard deviations between independent trials were very
small which would indicate a consistency of DNA breaks in all experiments. All
compared control and treatment conditions were performed with the same batch of
enzymes and materials to facilitate consistency. This should ensure that the “no I-Sce1
induced break” levels remain consistent throughout all experiments.
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The ratio of repair outcomes in the double positive quadrant will certainly change
depending on what the experimental condition is. Unfortunately, the “no I-Sce1 induced
break”, precise ligation without processing and perfect HR will all present with the same
genomic configuration. While it was outside the scope of this project, it would be
possible to generate some quantitative numbers of homology dependent repair vs nonhomology dependent repair if next generation sequencing was employed. FACS of the
double positive quadrant would be required, followed by NGS and analysis. An attempt
was made to decipher changes in the homology dependent vs non-homology dependent
repair of the treatment vs control conditions, by performing PCR of the polyclonal
population with primers on each side flanking the I-Sce1 restriction site. After PCR, the
products were subjected to in vitro digestion by I-Sce1. The theory is that the NHEJ
events would then be resistant to in vitro digestion and the percent change of treatment
conditions could be quantified from product intensities on a gel. The results of this
experiment were inconclusive. Perhaps an alternative to this method would be single
droplet PCR but that technology was not available to the investigator. Due to the
uncertainty of the type of DNA repair found in the double positive quadrant, this project
primarily focused on the better defined repair outcomes of the red, green, and double
negative quadrants.

FANCT is involved in homology dependent and non-homology dependent
DNA repair
FANCT was recently implicated in the etiology of a Fanconi anemia patient with
genomic rearrangements of both FANCT alleles (Virts et al., 2015). The FA pathway has
been characterized in the resolution of deleterious interstrand crosslinks (Wang &
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Smogorzewska, 2015). FANCT is the E2 ubiquitin conjugase that performs the transfer
of ubiquitin to the E3 ubiquitin ligase FANCL that will ubiquitinate the FANC I/D
complex (Rickman et al., 2015b). It is currently unknown if FANCT is involved in other
DNA repair events outside of the FA pathway. The well-established DR-GFP cell
reporter system and the newly defined DF system were both employed in an attempt to
answer the question of FANCT’s role in additional DNA repair pathways. The DR-GFP
reporter system is widely used as reporter system to assay for homology directed repair
(Moynahan & Jasin, 2010). The major drawback of this system is there is only a
fluorescent readout for HDR events, not non-homology dependent events. The DF
system is capable of defining both HDR and non-HDR events using fluorescence
detection by flow cytometry. This experiment was designed with two questions in mind.
First, does the DF system compare similarly to the established DR-GFP system in its
ability to detect HDR events. Second, is to determine if FANCT is involved in HDR and
non-HDR DNA repair by use of the DF system.
To achieve the goal of determining FANCT’s role in DNA repair, both the DRGFP and DF3 cell lines were subjected to CRISPR mediated knockout of FANCT. For
the DR-GFP system HDR was reduced to approximately 60% relative to the control cell
line after an I-Sce1 mediated DNA break. HDR was restored to near control levels by
adding back a vector expressing FANCT which confirms that the effect displayed was
due to loss of FANCT. In the DF3 cell line, the results also revealed a decrease in green
fluorescence of approximately 60% relative to the control cell line after an I-Sce1
mediated DNA break. Additionally, the DF system displays an approximate 50%

97

decrease in double negative recombinants when compared to the control after an I-Sce1
induced DNA break.
The results from this experiment demonstrate several things. First, the DF system
is comparable to the well-established DR-GFP system when assessing the ability to detect
HDR events. Second, the findings here reveal that FANCT can play a role in homology
dependent and non-homology dependent DNA break repair. This repair is independent
of the interstrand crosslink resolution function in FA pathway since no crosslinking
agents were used.

DNA repair is not detected in replication challenged DF3 microsatellite model
cell lines
The previous experiments have established the DF system as capable of emulating
the reversion pattern witnessed in the FANCT patient. It is unknown exactly where and
why the initial DNA break occurred in the FANCT patient, only that the patient had
encountered a reversion of the maternal duplication to WT due to Alu mediated
recombination in the hematopoietic linage. Genomic reversions have occurred in other
Fanconi anemia patients and in some subsets the breakpoint can be narrowed down to a
microsatellite motif (Benhammou et al., 2011; Gregory et al., 2001; Levran et al., 1997).
Therefore, it would be pertinent to evaluate the effect of a microsatellite sequence within
the ectopic site of the DF system. If the microsatellite sequence can initiate a DNA
break, then subsequent repair can be monitored by flow cytometry. Previous research has
revealed that microsatellite sequences can be a source of instability in the form of DNA
expansions or contractions (Usdin & Grabczyk, 2000). While genomic instability of
microsatellite sequences are well documented, exactly how the instability occurs in
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human cells is not unanimously accepted. It has been posited that instability can occur
due to DNA replication, transcription coupled repair or other DNA repair processes (Liu
et al., 2009; McMurray, 2010; Nakamori et al., 2011). Replication inhibitors have been
used to help induce genomic instability, presumably by increasing single strand DNA at
the replication fork that lends more opportunity for non-B DNA secondary structures to
form (Liu et al., 2012). With the DF3 TNR and Pu/Py model cell lines it is possible to
test if the use of replication inhibitors can elicit a DNA break and recombination event
involving the microsatellite sequence. The c-Myc replicator was also added to the cell
lines because previous studies have demonstrated that instability is more likely the closer
the microsatellite sequence is to a replication origin (Liu, 2010) . Additionally, the cMyc replicator allows for a determination if replication polarity will influence the
outcome.
Aphidicolin (0.2 uM) and hydroxyurea (0.2 mM) were utilized as replication
inhibitors for this experiment. The low concentrations of the replication inhibitors
aphidicolin (Casper et al., 2002; Glover et al., 1984b; Schwartz et al., 2006) and
hydroxyurea (Chen et al., 2015) (Petermann & Helleday, 2010b) will slow the replicative
polymerases but not arrest replication. Both were constantly in media for seven days and
then the cells recovered for four days and harvested for analysis. The results from this
experiment did not reveal any shift in fluorescence of the CAG84, CTG100, TR or TF cell
lines when compared to the c-Myc only control cell line. Initially, this was an
unexpected result considering the amount of literature that substantiate microsatellite
sequences as points of instability. Although the genomic rearrangement of microsatellite
sequences are rare events in vivo, the hope is that the highly sensitive flow cytometry
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assay could detect even small changes. By microscopic evaluation there was marginal
additional cell death observed (<5%) in the replication inhibitor treated, microsatellite
containing, cell lines when compared to the c-Myc only cell line.
In the replication inhibitor experiments it is unknown where a break may occur
within the microsatellite sequence, and there is a possibility that after a DSB the DNA
ends will not be “clean” (readily ligatable). The broken DNA ends could be “dirty” and
would require more processing enzymes to repair the DNA break (Boiteux & JinksRobertson, 2013; Kanaar et al., 2008). Combined with the possibility that the
microsatellite sequence can intramolecularly “fall back” on itself once single stranded
and form a structured end, even more processing enzymes may need to be involved. This
could impede repair and detection to an already rare event in the replication inhibitor
experiments.
An alternative hypothesis may be able to explain why no genomic instability was
detected in the DF3 microsatellite models after replication inhibitor treatment. The
outcome may be influenced by where the centromere is located relative to the ectopic
sequence. If the centromere is located downstream of the ectopic sequence then the
fluorescent markers could be linked. The end result after an unrepaired DNA double
strand break in the microsatellite sequence is the upstream portion (telomeric) of the
chromosome could become acentric after mitosis. The downstream portion of the broken
chromosome, containing both color marker genes would migrate with the centromere and
the cell could appear as double positive because both fluorescent markers are present.
The construction of the DF2 CTG100 cell line, which placed the microsatellite
sequence between the fluorescent markers can be used as tool to elucidate a possible
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explanation for the lack of genomic instability detection (Gadgil et al., 2016). When the
DF2 CTG100 cell line was subjected to the same regimen of aphidicolin (0.2 uM) and
hydroxyurea (0.2 mM) the results were dramatically different than the DF3 microsatellite
cell line results. The DF2 cell line is expected to lose eGFP and the cells would drift
from the double positive to the red quadrant. If the proposed theory of acentric
chromosome is valid then in the DF2 CTG100 model, the outcome of the replication
inhibitor experiments should be a shift to green fluorescence due to the eGFP being still
linked with the centromere. The result of replication inhibitor treatment is a dramatic
shift toward the green quadrant, therefore supporting the theory of an acentric
chromosome (Figure 40). More validation will need to be performed before it is certain
the interpretation of this result is correct. The cells could be FACS sorted and single cell
clones grown that could then be used for FISH assays to map the centromere with the
Tom and eGFP fragments.

Secondary structure forming sequences influence DNA repair patterns in
human cells
The results of the DF microsatellite cell line experiments can provide additional
depth to the current knowledge of what happens when a DNA break occurs within or
adjacent to a microsatellite sequence in human cells. The DF3 and DF2 microsatellite
cell line experiments provide evidence to infer that a DNA break within or near a
microsatellite sequence may be recalcitrant to repair. The model cell lines were created
so that an I-Sce1 recognition site was located immediately downstream of the
microsatellite sequences. The hypothesis is that after the I-Sce1 induced DSB and 5’
resection, it will expose ssDNA of the microsatellite sequences that has the possibility to
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form secondary structures and structured DNA ends. Just the secondary structure alone
could form a physical impediment or the secondary structure could preclude canonical
DNA repair proteins from performing their functions. The results of this experiment
indicate that secondary forming sequences juxtaposed to a DNA break in human cells can
influence recombination patterns. This is consistent with previous work that shows
structured DNA can inhibit the processing of DNA double strand breaks (Bikard et al.,
2010; Wang & Vasquez, 2014; Wang et al., 2014).
In the trinucleotide repeat cell lines there is significant reduction of recombinants
in the double negative and green quadrants after an I-Sce1 induced DNA break of the
CAG84 and CTG100 cell lines (68% and 75% green, 57% and 60% double negative)
respectively, when compared to the DF3 Myc cell line. The slightly higher decrease in
recombinants of the CTG100 cell line may stem from the fact that formation of CTG is
favorable to CAG secondary structures due to less steric hindrance of the pyrimidine (T)
relative to purine (A) or simply just more repeats in the CTG100 cell line. The decrease in
double negative and green quadrant recombinants for either cell line may be explained by
the resection process. Among several explanations for this result, one is that once
resection has occurred, the exposed ssDNA TNR tract forms secondary structure that
impedes repair proteins or the repair process; the second is that when the helicase
separates the DNA strands allowing for resection, it offers opportunity for secondary
structure formation that can impede the actual resection process and may cause it to
abort. Either of these scenarios could interrupt the long range resection process and
result in an unrepaired DNA break or restrict to short range resection and NHEJ. Both of
these outcomes could result in a double positive cell that retains both fluorescent markers.
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The triplex forming TF and TR models also exhibit a reduction in the number of
double negative and green quadrant recombinants when compared to the DF3 Myc
control cell line, after an I-Sce1 induced DNA break. The TF cell line had a higher
reduction of recombinants than any of the experimental cell lines (86% green and 76%
double negative) RTC. In comparison, the TR cell line exhibited less of a reduction than
the TF cell line, with a reduction of (66% green and 52% double negative) when
compared to the c-Myc only control cell line. From a strictly steric hindrance point of
view the Py-rich strand should form secondary structure easier than the Pu-rich strand
simply due to less bulky structures. In contrast, previous results have displayed the
tendency at physiological pH is for the Pu-rich strand to preferentially form DNA
secondary triplex and G-quadraplex structures (Inoue, 2005). This theory was
substantiated from a replication viewpoint with primer extension and replication blockage
experiments (Liu, Myers, et al., 2012). It is unclear exactly what DNA secondary
structures the Pu-Py sequence will conform to when a juxtaposed DSB occurs in human
cells. While a Py-rich third strand triplex is not thought to occur under physiological
conditions with intact DNA strands, it has been observed that after a DSB, the 3’ ssDNA
of the Py-rich strand and the 5’ ssDNA of the Pu-rich strand will preferentially fold back
to form secondary structures in vivo (Jain, Wang, & Vasquez, 2008). It has also been
observed that a DSB will contribute to a favorable relaxed DNA supercoiling condition
as to promote triplex DNA structures in Saccharomyces cerevisiae (Wang & Vasquez,
2014). The results of these experiments can provide a framework by which the outcome
of the TF and TR cell line assays can be explained. After I-Sce1 produces a DSB,
bidirectional 5’ DNA resection occurs that will expose the Py-rich (TF) or the Pu-rich
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(TR) 3’ DNA sequence. The TF cells would therefore produce a 3’ Py-rich tail that could
fall back on the still double stranded duplex DNA forming a triplex structure. This
triplex structure could then prevent the recruitment of canonical DNA repair proteins and
possibly even disrupt longer range resection. The disruption of longer range resection
could potentiate multiple outcomes such as a short range non-HDR event or an
unrepaired acentric chromosome. Both of these outcomes would result in the possible
retention of both fluorescent markers and present in the double positive quadrant.
While the results of the DF microsatellite and I-Sce1 experiments display a
definite modulation in recombination patterns, more assays would need to be performed
to tease apart all recombination fates. As alluded to earlier, after I-Sce1 expression, there
would be a need to separate the heterogeneous cell population by fluorescent quadrants.
Once the recombinant cells are separated by fluorescence, the next step would be to
define the different DNA recombination patterns from each quadrant. Single cell sorting
by fluorescence followed by DNA sequencing could achieve this aim, but takes
considerable time to grow individual cells into colonies in order to generate enough
starting material. An alternate, quicker, method would be to perform droplet PCR and
sequencing or next generation sequencing on the recombinant cells from each quadrant.
The goal would be to generate enough data to provide quantitative statistical relevance to
the DNA recombination outcomes.
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FUTURE DIRECTIONS
The work presented in this project provides a basis as to what factors may lead to
the FANCT genomic reversion presented in the hematopoietic cells of a FANCT patient.
The novel DF cell line model system has potential to be a very powerful system to detect
what type of recombination is occurring under differing experimental conditions. The
experiments performed within this project have helped define the different DNA
recombination possibilities for each quadrant but more work needs to be completed to
ensure the results are not hyperbolized. It is possible that any decrease of cells within a
quadrant, relative to control, could be due to cells within that quadrant dying off during
the recovery period. To address this possibility, cell viability assays and next generation
sequencing can be performed at different time points throughout the recovery period to
further refine what type of recombination results are presented for each flow cytometry
quadrant. Since the FANCT reversion occurred preferentially in the hematopoietic cell
lineage of the patient, it would be prudent to also modulate levels of hematopoietic
specific proteins in the DF cell lines. AID and RAG recombinase are both known to
induce recombination in hematopoietic cells, and their activity could possibly potentiate
the reversion observed in the FANCT patient. The DF microsatellite cell line models also
need to be probed further to determine if the results of the DF3 microsatellite cell lines
are due to lack of repeat instability, or if it is just difficult to detect with the design of the
system. It is possible that the DNA break is especially difficult to repair and cells will die
off or form an acentric chromosome and only present with one fluorescent marker. The
DF2 CTG100 cell line results indicate that an acentric chromosome is a definite possibility
and cell viability and FISH assays can be performed to address these issues.
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CONCLUSION
This project presents data that FANCT’s role in DNA repair expands beyond
resolution of interstrand crosslinks via the FA pathway. The experimental DF model
system was successful in emulating the Alu mediated recombination found in the
genomic reversion of the FANCT patient. The novel DF model system has shown to be
equivalent to the well accepted U2-OS DR-GFP model system for detection of homology
directed repair and was developed to assist in the interrogation of FANCT’s role in
repair. Results from this project also demonstrates the ability of the DF model system to
be used as method for detection of both homology and non-homology directed repair.
The DF3 microsatellite cell line experiments provides evidence that a DNA break near a
microsatellite element can modulate the DNA recombination outcomes. This project
expands the current knowledge of FANCT and DNA microsatellite roles in DNA repair
fates, in addition to developing a diagnostic tool for simultaneous examination of
homology and non-homology directed DNA repair.
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